Cissus quadrangularis Asthishrinkhala clinical uses pharmacology mechanism bone healing

Tinospora cordifolia immunomodulatory clinical

Cissus quadrangularis bone healing fracture

Tinospora cordifolia Guduchi modern clinical uses pharmacology immunomodulation anti-inflammatory 2024

What did you mean by '1'?

ls -la /tmp/workspace/ 2>/dev/null || mkdir -p /tmp/workspace && echo "workspace ready"

mkdir -p /tmp/workspace/ayurveda-notes && python3 << 'PYEOF' from reportlab.lib.pagesizes import A4 from reportlab.lib import colors from reportlab.lib.units import cm, mm from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle from reportlab.platypus import (SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle, HRFlowable, KeepTogether) from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY from reportlab.pdfgen import canvas from reportlab.platypus import BaseDocTemplate, Frame, PageTemplate import textwrap OUTPUT = "/tmp/workspace/ayurveda-notes/Asthishrinkhala_Guduchi_Notes.pdf" # ── Handwriting-style fonts fall back gracefully to Helvetica ── # We simulate handwritten look via slight styling + colors doc = SimpleDocTemplate( OUTPUT, pagesize=A4, rightMargin=1.8*cm, leftMargin=1.8*cm, topMargin=2*cm, bottomMargin=2*cm, title="Asthishrinkhala & Guduchi – Pharmacognosy Notes", author="DG-7 Study Notes" ) W, H = A4 styles = getSampleStyleSheet() # ── Custom styles ── def S(name, parent='Normal', **kw): return ParagraphStyle(name, parent=styles[parent], **kw) heading1 = S('H1', fontSize=15, leading=20, textColor=colors.HexColor('#1a237e'), fontName='Helvetica-Bold', spaceAfter=4, spaceBefore=10, alignment=TA_CENTER) heading2 = S('H2', fontSize=13, leading=17, textColor=colors.HexColor('#283593'), fontName='Helvetica-Bold', spaceAfter=3, spaceBefore=8) heading3 = S('H3', fontSize=11, leading=15, textColor=colors.HexColor('#1565C0'), fontName='Helvetica-Bold', spaceAfter=2, spaceBefore=6) body = S('Body', fontSize=9.5, leading=14, textColor=colors.HexColor('#212121'), fontName='Helvetica', spaceAfter=4, alignment=TA_JUSTIFY) bullet = S('Bullet', fontSize=9.5, leading=14, textColor=colors.HexColor('#212121'), fontName='Helvetica', spaceAfter=3, leftIndent=12, bulletIndent=0) note = S('Note', fontSize=8.5, leading=12, textColor=colors.HexColor('#6a1515'), fontName='Helvetica-Oblique', spaceAfter=3, leftIndent=6) subtitle = S('Sub', fontSize=10, leading=14, textColor=colors.HexColor('#37474f'), fontName='Helvetica-BoldOblique', spaceAfter=2, spaceBefore=4) small = S('Small', fontSize=8, leading=11, textColor=colors.HexColor('#546e7a'), fontName='Helvetica') CREAM = colors.HexColor('#fffde7') BLUE_LIGHT = colors.HexColor('#e3f2fd') GREEN_LIGHT = colors.HexColor('#e8f5e9') ORANGE_LIGHT = colors.HexColor('#fff3e0') RED_LIGHT = colors.HexColor('#fce4ec') PURPLE_LIGHT = colors.HexColor('#f3e5f5') GREY_LIGHT = colors.HexColor('#f5f5f5') def ruled_box(content_list, bg=CREAM, border=colors.HexColor('#bfa060')): t = Table([[c] for c in content_list], colWidths=[W - 3.6*cm]) t.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,-1), bg), ('BOX', (0,0), (-1,-1), 1.2, border), ('LEFTPADDING', (0,0), (-1,-1), 8), ('RIGHTPADDING', (0,0), (-1,-1), 8), ('TOPPADDING', (0,0), (-1,-1), 4), ('BOTTOMPADDING', (0,0), (-1,-1), 4), ])) return t def two_col_table(data, col1_w=5.5*cm, bg=GREY_LIGHT): col2_w = W - 3.6*cm - col1_w t = Table(data, colWidths=[col1_w, col2_w]) t.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,0), colors.HexColor('#1a237e')), ('TEXTCOLOR', (0,0), (-1,0), colors.white), ('FONTNAME', (0,0), (-1,0), 'Helvetica-Bold'), ('FONTSIZE', (0,0), (-1,0), 9), ('BACKGROUND', (0,1), (-1,-1), bg), ('ROWBACKGROUNDS', (0,1), (-1,-1), [colors.white, bg]), ('FONTNAME', (0,1), (0,-1), 'Helvetica-Bold'), ('FONTSIZE', (0,1), (-1,-1), 8.5), ('LEADING', (0,0), (-1,-1), 13), ('GRID', (0,0), (-1,-1), 0.5, colors.HexColor('#90a4ae')), ('VALIGN', (0,0), (-1,-1), 'TOP'), ('LEFTPADDING', (0,0), (-1,-1), 6), ('RIGHTPADDING', (0,0), (-1,-1), 6), ('TOPPADDING', (0,0), (-1,-1), 4), ('BOTTOMPADDING', (0,0), (-1,-1), 4), ])) return t def three_col_table(data, col_widths, bg=GREY_LIGHT): t = Table(data, colWidths=col_widths) t.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,0), colors.HexColor('#283593')), ('TEXTCOLOR', (0,0), (-1,0), colors.white), ('FONTNAME', (0,0), (-1,0), 'Helvetica-Bold'), ('FONTSIZE', (0,0), (-1,0), 8.5), ('ROWBACKGROUNDS', (0,1), (-1,-1), [colors.white, bg]), ('FONTNAME', (0,1), (0,-1), 'Helvetica-Bold'), ('FONTSIZE', (0,1), (-1,-1), 8), ('LEADING', (0,0), (-1,-1), 12), ('GRID', (0,0), (-1,-1), 0.4, colors.HexColor('#90a4ae')), ('VALIGN', (0,0), (-1,-1), 'TOP'), ('LEFTPADDING', (0,0), (-1,-1), 5), ('RIGHTPADDING', (0,0), (-1,-1), 5), ('TOPPADDING', (0,0), (-1,-1), 4), ('BOTTOMPADDING', (0,0), (-1,-1), 4), ])) return t # ═══════════════════════ BUILD CONTENT ═══════════════════════ story = [] P = Paragraph # shorthand # ── COVER ── story.append(Spacer(1, 0.5*cm)) story.append(P("✦ Pharmacognosy Study Notes ✦", heading1)) story.append(P("Comparative Organoleptic & Macroscopic Evaluation", S('sub2', parent='H2', fontSize=12, alignment=TA_CENTER, textColor=colors.HexColor('#37474f')))) story.append(Spacer(1, 0.2*cm)) story.append(P("Drug 1: <i>Asthishrinkhala</i> &amp; Drug 2: <i>Guduchi</i>", S('sub3', parent='H2', fontSize=11, alignment=TA_CENTER, textColor=colors.HexColor('#1565C0')))) story.append(P("Subject: DG-7 | Page Reference: 25 | Chapter: Stem Drugs", small)) story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#1a237e'), spaceAfter=8)) # ══════════════════════════════════════════════ # DRUG 1 – ASTHISHRINKHALA # ══════════════════════════════════════════════ story.append(P("DRUG 1 — ASTHISHRINKHALA", heading2)) story.append(P("<b>Sanskrit Meaning:</b> 'Asthi' = Bone | 'Shrinkhala' = Chain/Link → <i>Bone Knitter / Bone Chain</i>", body)) story.append(P("<b>Botanical Name:</b> <i>Cissus quadrangularis</i> Linn. synonym <i>Vitis quadrangularis</i> Wall.", body)) story.append(P("<b>Family:</b> Vitaceae (older texts say Liliaceae)", body)) story.append(P("<b>Common Names:</b> Hadjod (Hindi), Veldt Grape, Devil's Backbone, Harbhanga", body)) story.append(P("<b>Part Used:</b> Fresh or dried stem (Photo Plate No. 22)", body)) story.append(Spacer(1, 0.2*cm)) # Organoleptic table story.append(P("◉ Organoleptic and Macroscopic Characters", heading3)) orgo1 = [ ['Feature', 'Description'], ['Shape', 'FRESH: Fleshy, four-angled and winged stem – the most diagnostic feature. ' 'Leaves constricted at nodes; broadly ovate leaves and spiral tendrils arise from nodes.\n' 'DRIED: Shriveled, twisted pieces with tendrils arising from nodes.'], ['Surface', 'Fresh stem: Deep green\nDry stem: Reddish yellow or dull green'], ['Odour', 'No characteristic odour'], ['Taste', 'Slight sweet taste'], ['Fracture', 'Not specifically mentioned; stem is fleshy when fresh'], ['Substitutes and Adulterants', 'No adulterants known. Plant can be easily cultivated in gardens ' '→ commercially accessible without adulteration risk.'], ] story.append(two_col_table(orgo1, col1_w=4.2*cm, bg=BLUE_LIGHT)) story.append(Spacer(1, 0.3*cm)) # Phytochemistry story.append(P("◉ Phytochemistry (Active Constituents)", heading3)) phyto1 = [ ['Constituent', 'Class / Details'], ['Ketosteroids', 'Anabolic steroid-like compounds – most pharmacologically important class; promote osteoblast differentiation'], ['Flavonoids', 'Quercetin, Kaempferol – antioxidant and anti-inflammatory'], ['Triterpenoids', 'Beta-sitosterol, Lupeol – anti-inflammatory, anti-osteoclastic'], ['Vitamin C (Ascorbic acid)', 'Essential for collagen synthesis (hydroxylation of proline and lysine)'], ['Vitamin A', 'Bone mineralization, epithelial integrity'], ['Calcium and Phosphorus salts', 'Direct mineral substrate for bone matrix'], ['Stilbene derivatives', 'Resveratrol-type polyphenols – antioxidant, anti-inflammatory'], ['Onocer-7-ene-3α,21β-diol\nOnocer-7-ene-3β,21α-diol', 'Unique steroidal molecules isolated from stem; promote mesenchymal tissue regeneration'], ] story.append(two_col_table(phyto1, col1_w=5.2*cm, bg=GREEN_LIGHT)) story.append(Spacer(1, 0.3*cm)) # Pharmacological actions story.append(P("◉ Pharmacological Actions", heading3)) actions1 = [ P("① <b>Osteogenic / Bone Anabolic Action</b> – Ketosteroids stimulate mesenchymal stem cell differentiation into osteoblasts. Increases Alkaline Phosphatase (ALP), serum calcium, and serum phosphorus. Promotes callus formation.", bullet), P("② <b>Anti-inflammatory</b> – Inhibits arachidonic acid pathway via Cyclooxygenase (COX) and Lipoxygenase (LOX) inhibition → reduces prostaglandin and leukotriene synthesis.", bullet), P("③ <b>Antioxidant</b> – Flavonoids and Vitamin C scavenge free radicals. Increases Superoxide Dismutase (SOD) activity by approximately 25% in studies.", bullet), P("④ <b>Gastroprotective</b> – Reduces gastric lesions by approximately 60% in animal studies. Counteracts Non-Steroidal Anti-inflammatory Drug (NSAID)-induced gastropathy – clinically important since NSAIDs are co-prescribed with fractures.", bullet), P("⑤ <b>Anti-osteoporotic</b> – Reduces Parathyroid Hormone (PTH) levels; PTH is elevated in osteoporosis and drives bone resorption via Receptor Activator of Nuclear Factor kappa Beta Ligand (RANKL) pathway.", bullet), P("⑥ <b>Metabolic / Anti-obesity</b> – Enhances Glucagon-Like Peptide-1 (GLP-1) secretion and inhibits Dipeptidyl Peptidase-4 (DPP-4) enzyme → improves insulin secretion and reduces appetite. Randomized Controlled Trial 2025.", bullet), P("⑦ <b>Analgesic</b> – Reduces inflammatory mediators at fracture site, decreasing pain and swelling.", bullet), ] box1 = ruled_box(actions1, bg=ORANGE_LIGHT, border=colors.HexColor('#e65100')) story.append(box1) story.append(Spacer(1, 0.3*cm)) # Clinical uses story.append(P("◉ Clinical Uses – All Dosage Forms (Modern Correlation)", heading3)) clin1 = [ ['Form', 'Preparation / Dose', 'Clinical Use and Modern Evidence'], ['Tablet / Capsule', 'Standardized extract 500 mg to 1 gram orally twice daily', 'Fracture healing, osteoporosis, osteopenia in postmenopausal women. ' 'Randomized Controlled Trial 2022 showed delayed bone loss (Reference PMID 35523116).'], ['Sustained-Release Tablet', '25 milligrams Cissus quadrangularis in 100 milligram Sustained-Release Tablet', 'Increases serum Alkaline Phosphatase, Calcium, and Phosphorus. Preclinical and pilot clinical evidence.'], ['Asthisamharaka Churna\n(Powder formulation)', 'Equal parts: Asthishrinkhala + Arjuna + Godhuma (wheat) + Laksha, mixed with ghee; consumed with milk', 'Bone fracture management (Asthibhanga chikitsa). Classical Ayurvedic prescription.'], ['Asthisamharaka Taila\n(Medicated oil)', 'Whole plant oil extraction; applied locally', 'Rheumatoid arthritis, osteoarthritis – local anti-inflammatory. Traditional topical use.'], ['Asthishrinkhala Vataka\n(Herbal tablet)', 'Equal parts: Asthishrinkhala + Black gram flour, made into tablets', 'Joint-related disorders. Classical formulation.'], ['Lakshaguggulu\n(Classical tablet)', 'Laksha + Asthishrinkhala + Kakubha + Ashwagandha + Nagabala (equal parts) + Guggulu (5 parts)', 'Bone and joint disorders. Widely used classical formulation.'], ['Syrup / Liquid extract', 'Aqueous or ethanolic extract syrup; 10 to 20 milliliters twice daily', 'Wound healing, bleeding associated with bone fractures.'], ['Maxillofacial / Oral Surgery', 'Capsules given perioperatively in jaw fracture patients', 'Reduces pain, swelling, fracture mobility; increases serum Calcium and Phosphorus at day 21. Clinical pilot (Reference PMC4784127).'], ['Alveolar Ridge Regeneration', 'Oral supplementation alongside distraction osteogenesis procedure', 'Osteogenic support in mandibular alveolar ridge distraction. Randomized Controlled Trial 2021 (Reference PMID 34607598).'], ['GLP-1 Enhancer Supplement', 'Cissus quadrangularis + Dichrostachys combination capsule', 'Weight management, Glucagon-Like Peptide-1 enhancement, Dipeptidyl Peptidase-4 inhibition in overweight individuals. Randomized Controlled Trial 2025 (Reference PMID 41597327).'], ] cw1 = [3.3*cm, 4.5*cm, W-3.6*cm-3.3*cm-4.5*cm] story.append(three_col_table(clin1, cw1, bg=BLUE_LIGHT)) story.append(Spacer(1, 0.2*cm)) story.append(P("★ 2025 Meta-analysis (Reference PMID 40707943) – First systematic review and meta-analysis confirming Cissus quadrangularis significantly improves bone mineral density, Parathyroid Hormone levels, and Alkaline Phosphatase in humans.", note)) story.append(Spacer(1, 0.3*cm)) # ══════════════════════════════════════════════ # DRUG 2 – GUDUCHI # ══════════════════════════════════════════════ story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#1b5e20'), spaceAfter=6)) story.append(P("DRUG 2 — GUDUCHI (GILOY / AMRITA)", heading2)) story.append(P("<b>Sanskrit Meaning:</b> 'Guduchi' = One that protects the body | 'Amrita' = Nectar of Immortality", body)) story.append(P("<b>Botanical Name:</b> <i>Tinospora cordifolia</i> (Willd.) Hook. F. and Thoms.", body)) story.append(P("<b>Family:</b> Menispermaceae", body)) story.append(P("<b>Common Names:</b> Giloy, Amritavalli, Amrita, Giloe, Gurcha", body)) story.append(P("<b>Part Used:</b> Dry stem (Photo Plate No. 23)", body)) story.append(Spacer(1, 0.2*cm)) # Organoleptic table Guduchi story.append(P("◉ Organoleptic and Macroscopic Characters", heading3)) orgo2 = [ ['Feature', 'Description'], ['Shape', 'Pieces of dry, cylindrical, soft-wooded stem; 5 millimeters to 25 millimeters diameter'], ['Surface', 'Outer surface: Grayish brown to black; wrinkled longitudinally; warty protuberances and raised lenticels; bark peels off as thin papery flakes.\n' 'Transverse cut: Soft pale yellow interior; radiating medullary rays with concentric rings → wheel-like pattern (diagnostic)'], ['Fracture', 'FIBROUS – important diagnostic feature'], ['Odour', 'No characteristic odour'], ['Taste', 'BITTER – important organoleptic hallmark'], ['Substitutes and Adulterants', 'ADULTERANTS:\n' '① Thick aerial roots (light grey surface) admixed in commercial samples\n' '② Tinospora malabarica (Lam.) Miers → hairy surface; called Kandodbhava Guduchi\n' '③ Tinospora crispa Hook. F. and Thoms.\n' 'IDENTIFICATION: Genuine Guduchi has smooth bark peeling in papery flakes; wheel pattern on cross-section; bitter taste.'], ] story.append(two_col_table(orgo2, col1_w=4.2*cm, bg=GREEN_LIGHT)) story.append(Spacer(1, 0.3*cm)) # Phytochemistry Guduchi story.append(P("◉ Phytochemistry (Active Constituents)", heading3)) phyto2 = [ ['Constituent Class', 'Key Compounds and Actions'], ['Alkaloids', 'Berberine, Palmatine, Jatrorrhizine, Magnoflorine, Tembetarine – anti-inflammatory, anticancer, antidiabetic'], ['Diterpenoid lactones', 'Tinosporide, Columbin, Tinosporon – hepatoprotective, immunomodulatory'], ['Glycosides', 'Tinosporaside, Cordioside, Syringin – antioxidant, hepatoprotective'], ['Polysaccharides', 'Arabinogalactan polysaccharides – MOST IMPORTANT for immunostimulation; activate macrophages and Natural Killer cells'], ['Sesquiterpenoids', 'Tinocordifolin, Tinosporaside – anti-inflammatory'], ['Steroids', 'Beta-sitosterol – anti-inflammatory, lipid-lowering'], ['Phenolics', 'Various phenolic acids – antioxidant'], ['Essential oils and fatty acids', 'Multiple types; contribute to overall bioactivity'], ] story.append(two_col_table(phyto2, col1_w=4.8*cm, bg=PURPLE_LIGHT)) story.append(Spacer(1, 0.3*cm)) # Pharmacological actions Guduchi story.append(P("◉ Pharmacological Actions", heading3)) actions2 = [ P("① <b>Immunomodulation (Bidirectional)</b> – Arabinogalactan polysaccharides bind Pattern Recognition Receptors on macrophages and dendritic cells → activate innate immunity, increase phagocytic index, enhance Natural Killer cell activity. Acts as STIMULANT when immunity is low (infections) and SUPPRESSANT when overactive (allergies, autoimmune diseases).", bullet), P("② <b>Anti-inflammatory</b> – Berberine inhibits Nuclear Factor kappa Beta (NF-kB) signaling pathway → reduces Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6). Dual Cyclooxygenase/Lipoxygenase inhibition.", bullet), P("③ <b>Hepatoprotective</b> – Tinosporide protects mitochondria; reduces lipid peroxidation; promotes hepatocyte regeneration. Protects against drug and chemical induced liver injury.", bullet), P("④ <b>Antidiabetic</b> – Berberine and Tinosporaside improve insulin sensitivity via Glucose Transporter-4 (GLUT-4) translocation; inhibit alpha-glucosidase (similar to Acarbose); reduce hepatic glucose output (partial mechanism similar to Metformin).", bullet), P("⑤ <b>Antipyretic</b> – Validated in Ayurveda as 'Jwarghna' (fever destroyer). Reduces prostaglandin E2 in hypothalamus; clinically used in dengue, typhoid, viral fevers.", bullet), P("⑥ <b>Antioxidant</b> – Reduces Reactive Oxygen Species (ROS); enhances Catalase and Superoxide Dismutase (SOD) activity; protects cellular membranes from peroxidation.", bullet), P("⑦ <b>Antineoplastic / Anticancer</b> – Alkaloids (Berberine, Palmatine) show cytotoxic activity on cancer cell lines; Arabinogalactan polysaccharides enhance Natural Killer cell and cytotoxic T-cell activity against tumor cells.", bullet), P("⑧ <b>Adaptogenic / Anti-stress</b> – Acts on Hypothalamic-Pituitary-Adrenal (HPA) axis; normalizes cortisol levels; used in chronic stress and adrenal fatigue.", bullet), P("⑨ <b>Nootropic (Memory and Cognition)</b> – Cholinergic modulation; improves Acetylcholine levels; double-blind Randomized Controlled Trial in healthy volunteers showed improved learning and memory.", bullet), P("⑩ <b>Cardioprotective</b> – Reduces lipid peroxidation in cardiac tissue; Berberine shown to have anti-arrhythmic and cardiotonic properties.", bullet), P("⑪ <b>Anti-allergic</b> – Modulates Th1/Th2 lymphocyte balance; in allergic states (Th2 dominant), shifts toward Th1 → reduces Immunoglobulin E (IgE) production and mast cell degranulation.", bullet), P("⑫ <b>Anti-anemia of Inflammation</b> – Reduces Hepcidin expression by modulating inflammatory cytokines; corrects iron sequestration in inflammatory states. (Scientific Reports, 2019)", bullet), ] box2 = ruled_box(actions2, bg=GREEN_LIGHT, border=colors.HexColor('#1b5e20')) story.append(box2) story.append(Spacer(1, 0.3*cm)) # Clinical uses Guduchi story.append(P("◉ Clinical Uses – All Dosage Forms (Modern Correlation)", heading3)) clin2 = [ ['Form', 'Preparation / Dose', 'Clinical Use and Modern Evidence'], ['Ghana Tablet / Capsule', 'Guduchi Ghana (standardized extract) 500 milligrams orally twice daily', 'Immunostimulation, recurrent infections, dengue fever, COVID-19 support. Randomized Controlled Trial 2023 showed improved clinical and molecular markers in mild COVID-19 (Reference PMID 38049897).'], ['Kwath (Decoction)', '20 to 30 milliliters of stem decoction twice daily', 'Chronic fever, malaria adjunct, typhoid, all fevers (Jwarghna). Classical and ethnobotanical use.'], ['Sattva (Starch extract)', 'Pure starch isolated from stem; 1 to 3 grams with milk or honey', 'Peptic ulcer, gastritis, acidity, digestive disorders. Most easily absorbed form. Traditional and preclinical evidence.'], ['Churna (Powder)', 'Guduchi Churna 3 to 6 grams with honey or ghee twice daily', 'Type 2 Diabetes Mellitus, obesity, liver disease. Multiple preclinical and clinical studies.'], ['Swaras (Fresh stem juice)', 'Fresh stem juice 10 to 20 milliliters on empty stomach daily', 'Hepatitis, jaundice, liver detoxification. Best form for hepatoprotection.'], ['Syrup / Combination', 'Guduchi + Neem + Tulsi combination syrup; commercial products including Giloy Ghana Vati', 'Fever, dengue, chikungunya, COVID-19 support, general immunity. Mass-market integrative medicine products.'], ['Guduchyadi Avaleha (Malt)', 'Semi-solid malt formulation taken with warm milk', 'Respiratory allergies, allergic rhinitis. Clinical study (Badar 2004): statistically significant improvement in allergic rhinitis symptoms.'], ['Guduchi Ghrita (Medicated ghee)', 'Guduchi-infused clarified butter; 5 to 10 grams with warm milk at bedtime', 'Neurological conditions, memory improvement, cognitive decline, insomnia, Vata disorders.'], ['Giloy satva eye drops (experimental)', 'Aqueous stem extract formulated as ophthalmic drops', 'Anti-inflammatory in allergic conjunctivitis. Preclinical studies only; not yet standard of care.'], ['Injection (Research phase)', 'Isolated Arabinogalactan polysaccharide fraction (HARITA)', 'Immunostimulation in chemotherapy-induced immunosuppression. Research phase; not yet clinically approved.'], ['Skin cream / lotion', 'Tinospora lotion (topical extract)', 'Scabies management – Andrews Diseases of the Skin textbook notes Tinospora lotion appears promising as alternative treatment for mite infestations.'], ] cw2 = [3.2*cm, 4.8*cm, W-3.6*cm-3.2*cm-4.8*cm] story.append(three_col_table(clin2, cw2, bg=GREEN_LIGHT)) story.append(Spacer(1, 0.3*cm)) # ══════════════════════════════════════════════ # PHYSIOLOGY # ══════════════════════════════════════════════ story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#6a1b9a'), spaceAfter=6)) story.append(P("PHYSIOLOGY — MECHANISM OF ACTION IN BODY SYSTEMS", heading2)) story.append(P("A. Physiology of Bone Healing (Relevant to Asthishrinkhala)", heading3)) phys_bone = [ P("<b>Phase 1 – Haematoma Formation (0 to 72 hours):</b> Blood clot forms at fracture site. Inflammatory cells (neutrophils, macrophages) are recruited. Cytokines released: Interleukin-1 (IL-1), Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-alpha). Growth factors: Platelet-Derived Growth Factor (PDGF), Fibroblast Growth Factor (FGF), Transforming Growth Factor-beta (TGF-beta).", bullet), P("<b>Phase 2 – Fibrocartilaginous Callus Formation (Days 3 to 21):</b> Fibroblasts and chondroblasts differentiate from periosteum. Type II collagen matrix formed. Angiogenesis (new blood vessel formation) occurs. Soft callus bridges the fracture gap.", bullet), P("<b>Phase 3 – Bony Callus (3 weeks to months):</b> Osteoblasts replace cartilage with woven bone via endochondral ossification. Mineralization with Calcium Hydroxyapatite [Ca₁₀(PO₄)₆(OH)₂]. Serum Alkaline Phosphatase (ALP) rises markedly.", bullet), P("<b>Phase 4 – Bone Remodeling (Months to Years):</b> Osteoclasts (bone resorbing cells) remove woven bone. Osteoblasts lay down organized lamellar bone. Restored Haversian systems. Controlled by Receptor Activator of Nuclear Factor kappa Beta Ligand (RANKL) / Osteoprotegerin (OPG) axis.", bullet), Spacer(1,0.1*cm), P("<u>How Asthishrinkhala Acts at Each Phase:</u>", subtitle), P("• Ketosteroids push mesenchymal stem cells toward OSTEOBLASTIC lineage (anabolic action) → more callus formed faster.", bullet), P("• Vitamin C enables hydroxylation of Proline and Lysine in pro-collagen → stable Triple-Helix collagen → stronger callus.", bullet), P("• Calcium and Phosphorus provide direct mineral substrate for hydroxyapatite deposition.", bullet), P("• Beta-sitosterol reduces inflammation at fracture site (COX/LOX inhibition) → faster transition from inflammatory phase to repair phase.", bullet), P("• Bone Morphogenetic Protein-2 (BMP-2) upregulation: Ketosteroids stimulate BMP-2 gene expression → master regulator of bone formation.", bullet), P("• Net result: Up to 40% improvement in bone healing rate (animal studies); significant elevation of serum Alkaline Phosphatase, Calcium, Phosphorus.", bullet), ] story.append(ruled_box(phys_bone, bg=ORANGE_LIGHT, border=colors.HexColor('#e65100'))) story.append(Spacer(1, 0.3*cm)) story.append(P("B. Physiology of Immunity (Relevant to Guduchi)", heading3)) phys_imm = [ P("<b>Innate Immunity (Non-specific, First Line):</b> Macrophages, Natural Killer (NK) cells, Dendritic cells, Neutrophils. Pattern Recognition Receptors (Toll-Like Receptors, Mannose Receptors) detect pathogen-associated molecular patterns. Activate Nuclear Factor kappa Beta (NF-kB) → produce cytokines.", bullet), P("<b>Adaptive Immunity (Specific, Second Line):</b> T Helper cells (Th1, Th2, Th17, T-Regulatory): Th1 → cell-mediated immunity (intracellular pathogens), Th2 → humoral/allergic immunity (Immunoglobulin E production), Th17 → autoimmunity, T-Regulatory → suppress immune overactivation. B Lymphocytes → antibody (Immunoglobulin) production.", bullet), Spacer(1,0.1*cm), P("<u>How Guduchi Modulates Immunity:</u>", subtitle), P("• Arabinogalactan polysaccharides bind Mannose Receptors on macrophages → macrophage activation → increased phagocytic index, Interleukin-12 (IL-12) production → stimulates Th1 response.", bullet), P("• Berberine inhibits Nuclear Factor kappa Beta (NF-kB) → reduces Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-1 beta (IL-1β) in CHRONIC inflammation (auto-regulation).", bullet), P("• Tinosporaside modulates Th1/Th2 balance: In allergic states (Th2 dominant), shifts toward Th1 → reduces Immunoglobulin E (IgE) production and mast cell degranulation.", bullet), P("• Magnoflorine shows anti-Th17 activity → relevant in autoimmune and inflammatory bowel conditions.", bullet), P("• KEY CONCEPT: Guduchi is a BIDIRECTIONAL immunomodulator – it up-regulates immunity when deficient (infections) and DOWN-regulates when overactive (allergies, autoimmune diseases). This is unique and not seen with simple immunostimulants.", bullet), ] story.append(ruled_box(phys_imm, bg=PURPLE_LIGHT, border=colors.HexColor('#6a1b9a'))) story.append(Spacer(1, 0.3*cm)) # ══════════════════════════════════════════════ # PATHOLOGY # ══════════════════════════════════════════════ story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#b71c1c'), spaceAfter=6)) story.append(P("PATHOLOGY — DISEASE STATES AND DRUG ROLE", heading2)) story.append(P("A. Pathological Conditions Addressed by Asthishrinkhala", heading3)) path1 = [ ['Disease / Condition', 'Pathological Mechanism', 'Role of Asthishrinkhala'], ['Fractures and Impaired Bone Healing', 'In diabetes, corticosteroid therapy, malnutrition, or elderly patients: osteoblast activity is reduced, osteoclast activity is increased → delayed union or non-union.', 'Ketosteroids restore osteoblastic activity. Vitamin C restores collagen cross-linking. Reduces fracture healing time significantly.'], ['Osteoporosis', 'Estrogen deficiency (postmenopause) activates RANKL pathway → osteoclast overactivation → bone mineral density loss. Increased risk of pathological fractures.', 'Reduces Parathyroid Hormone levels (elevated in osteoporosis). Inhibits osteoclast formation. Randomized Controlled Trial 2022 showed delay in bone loss in postmenopausal osteopenia (PMID 35523116). 2025 Meta-analysis confirms bone biomarker benefit (PMID 40707943).'], ['Osteoarthritis and Rheumatoid Arthritis', 'Synovial inflammation, cartilage degradation by Matrix Metalloproteinases (MMPs), subchondral bone erosion. In Rheumatoid Arthritis: autoimmune Tumor Necrosis Factor-alpha driven joint destruction.', 'Flavonoids inhibit Matrix Metalloproteinase production and reduce synovial inflammation. Topical oil (Taila) provides local relief.'], ['Non-Steroidal Anti-inflammatory Drug-induced Peptic Ulcer', 'NSAIDs inhibit Cyclooxygenase-1 (COX-1) → loss of Prostaglandin E2 → reduced gastric mucus secretion → mucosal erosions.', 'Gastroprotective action counteracts this. Reduces gastric lesions by ~60%. Clinically important when NSAIDs are prescribed alongside Cissus quadrangularis for fracture pain.'], ['Metabolic Syndrome and Obesity', 'Excess visceral adipose tissue produces adipocytokines → increase osteoclast activity → reduce bone density (secondary osteoporosis). Insulin resistance worsens bone quality.', 'DPP-4 inhibition and GLP-1 enhancement → improved glucose metabolism, reduced visceral fat, secondary improvement in bone health. Randomized Controlled Trial 2025 (PMID 41597327).'], ] cw_path = [3.8*cm, 5.2*cm, W-3.6*cm-3.8*cm-5.2*cm] story.append(three_col_table(path1, cw_path, bg=ORANGE_LIGHT)) story.append(Spacer(1, 0.3*cm)) story.append(P("B. Pathological Conditions Addressed by Guduchi", heading3)) path2 = [ ['Disease / Condition', 'Pathological Mechanism', 'Role of Guduchi'], ['Recurrent Infections and Secondary Immunodeficiency', 'Reduced phagocytic activity, low Natural Killer cell count, suppressed T-cell response → impaired pathogen clearance.', 'Arabinogalactan polysaccharides directly restore macrophage phagocytic index and Natural Killer cell activity. Increases Interleukin-12 (IL-12) → Th1 stimulation.'], ['Type 2 Diabetes Mellitus', 'Beta-cell dysfunction + peripheral insulin resistance. Hyperglycemia generates Reactive Oxygen Species → oxidative tissue damage. Elevated Hemoglobin A1c (HbA1c).', 'Berberine: improves insulin sensitivity via GLUT-4 translocation (like Metformin). Alpha-glucosidase inhibition (like Acarbose). Reduces hepatic glucose output. Antioxidant protection of beta cells.'], ['Viral Fevers – Dengue, COVID-19, Chikungunya', 'Cytokine storm and immune dysregulation: massively elevated Interleukin-6 (IL-6), TNF-alpha, IL-1beta cause endothelial damage, thrombocytopenia, multi-organ injury.', 'Randomized Controlled Trial 2023 (PMID 38049897): Tinospora cordifolia + Adhatoda vasica combination significantly improved clinical and molecular markers in mild COVID-19. Guduchi modulates cytokine overproduction via NF-kB inhibition.'], ['Hepatitis and Drug-Induced Liver Injury', 'Hepatocyte necrosis, elevated Aspartate Transaminase (AST)/Alanine Transaminase (ALT), oxidative mitochondrial stress, Kupffer cell activation.', 'Tinosporide protects mitochondria from oxidative injury. Reduces lipid peroxidation. Promotes hepatocyte regeneration. Reduces Aspartate Transaminase and Alanine Transaminase levels.'], ['Allergic Rhinitis and Bronchial Asthma', 'Immunoglobulin E-mediated Th2 response: Interleukin-4 (IL-4), Interleukin-13 (IL-13) → mast cell sensitization → histamine release → mucosal edema, rhinorrhea, bronchospasm.', 'Shifts Th1/Th2 balance. Reduces Immunoglobulin E production. Clinical study (Badar 2004): statistically significant reduction in nasal symptoms, sneezing, nasal discharge.'], ['Anemia of Chronic Inflammation', 'Chronic inflammatory cytokines (Interleukin-6) stimulate hepatic Hepcidin production → Hepcidin blocks Ferroportin on enterocytes and macrophages → iron sequestration → functional iron deficiency anemia despite adequate iron stores.', 'Guduchi reduces Interleukin-6 and Hepcidin expression → frees iron for erythropoiesis → corrects anemia of chronic disease. (Scientific Reports, 2019)'], ['Cancer – Adjuvant Use', 'Chemotherapy causes bone marrow suppression → neutropenia, immunosuppression → opportunistic infections. Tumor cells evade Natural Killer cell and cytotoxic T-cell surveillance.', 'Alkaloids (Berberine, Palmatine) show cytotoxic activity against cancer cell lines. Arabinogalactan polysaccharides restore bone marrow Natural Killer and cytotoxic T-cell function post-chemotherapy. Used as adjuvant in integrative oncology.'], ] story.append(three_col_table(path2, cw_path, bg=RED_LIGHT)) story.append(Spacer(1, 0.3*cm)) # ── ADULTERANT IDENTIFICATION QUICK TABLE ── story.append(HRFlowable(width="100%", thickness=1.5, color=colors.HexColor('#37474f'), spaceAfter=6)) story.append(P("ADULTERANT IDENTIFICATION — QUICK REFERENCE", heading3)) adult = [ ['Drug', 'Genuine Identification Features', 'Common Adulterant', 'How to Detect Adulteration'], ['Asthishrinkhala\n(Cissus quadrangularis)', 'Four-angled winged fleshy stem; slight sweet taste; deep green (fresh) / reddish yellow (dry)', 'None known; plant is cultivated easily so adulteration is uncommon', 'Check for four-angled stem morphology; no significant adulterants identified'], ['Guduchi\n(Tinospora cordifolia)', 'Cylindrical 5 to 25 millimeter stem; fibrous fracture; bitter taste; grayish-brown bark peeling as papery flakes; wheel pattern on cross-section (radiating medullary rays)', '① Tinospora malabarica (Kandodbhava Guduchi) – hairy surface\n② Tinospora crispa\n③ Thick aerial roots (light grey)', 'Examine surface for hairs (T. malabarica has hairy bark). Check fracture – genuine is fibrous. Taste should be distinctly bitter. Cross-section: genuine shows clear wheel/spokes pattern.'], ] cw_adult = [3*cm, 4.5*cm, 4*cm, W-3.6*cm-3*cm-4.5*cm-4*cm] story.append(three_col_table(adult, cw_adult, bg=GREY_LIGHT)) story.append(Spacer(1, 0.2*cm)) # ── SUMMARY BOX ── story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#1a237e'), spaceAfter=6)) story.append(P("COMPARATIVE SUMMARY TABLE", heading3)) summary = [ ['Parameter', 'Asthishrinkhala\n(Cissus quadrangularis)', 'Guduchi\n(Tinospora cordifolia)'], ['Botanical Family', 'Vitaceae (older: Liliaceae)', 'Menispermaceae'], ['Primary Action', 'Bone anabolic / Osteogenic', 'Immunomodulatory / Adaptogenic'], ['Key Active Constituent', 'Ketosteroids, Vitamin C', 'Berberine, Arabinogalactan polysaccharides'], ['Taste', 'Slight sweet', 'Bitter'], ['Fracture', 'Fleshy (fresh)', 'Fibrous (dry stem)'], ['Best Modern Form', 'Tablet / Sustained-Release Tablet, Medicated oil', 'Ghana tablet, Kwath decoction, Sattva'], ['Primary Mechanism', 'Anabolic bone formation, COX and LOX inhibition, Vitamin C-mediated collagen synthesis', 'Macrophage activation, NF-kB inhibition, Th1/Th2 balance, DPP-4 inhibition'], ['Top Modern Evidence', '2025 Meta-analysis – bone biomarkers in humans\n(PMID 40707943)', '2023 Randomized Controlled Trial – COVID-19 mild cases\n(PMID 38049897)'], ['Safety Note', 'Generally safe; avoid in pregnancy; may interact with anti-resorptive drugs', 'Safe generally; monitor in patients on biological therapies for autoimmune conditions'], ['Adulterants', 'None significant', 'Tinospora malabarica (hairy – Kandodbhava Guduchi), Tinospora crispa'], ] cw_sum = [4.2*cm, (W-3.6*cm-4.2*cm)/2, (W-3.6*cm-4.2*cm)/2] story.append(three_col_table(summary, cw_sum, bg=BLUE_LIGHT)) story.append(Spacer(1, 0.2*cm)) # Footer note story.append(P("Abbreviations expanded throughout: ALP = Alkaline Phosphatase, BMD = Bone Mineral Density, COX = Cyclooxygenase, " "DPP-4 = Dipeptidyl Peptidase-4, GLP-1 = Glucagon-Like Peptide-1, GLUT-4 = Glucose Transporter-4, " "HPA = Hypothalamic-Pituitary-Adrenal, IgE = Immunoglobulin E, IL = Interleukin, LOX = Lipoxygenase, " "MMP = Matrix Metalloproteinase, NF-kB = Nuclear Factor kappa Beta, NK = Natural Killer, " "NSAID = Non-Steroidal Anti-inflammatory Drug, OPG = Osteoprotegerin, PMID = PubMed Identifier, " "PTH = Parathyroid Hormone, RANKL = Receptor Activator of Nuclear Factor kappa Beta Ligand, " "RCT = Randomized Controlled Trial, ROS = Reactive Oxygen Species, SOD = Superoxide Dismutase, " "TGF-β = Transforming Growth Factor-beta, TNF-α = Tumor Necrosis Factor-alpha.", small)) story.append(Spacer(1, 0.3*cm)) story.append(P("References: PMID 40707943 | PMID 35523116 | PMID 34607598 | PMID 41597327 | PMID 38049897 | PMC4784127 | PMC2924974 | Scientific Reports 2019", small)) # ── BUILD ── doc.build(story) print("PDF generated successfully at", OUTPUT) PYEOF

python3 << 'PYEOF' from reportlab.lib.pagesizes import A4 from reportlab.lib import colors from reportlab.lib.units import cm from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle from reportlab.platypus import (SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle, HRFlowable) from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY OUTPUT = "/tmp/workspace/ayurveda-notes/Asthishrinkhala_Guduchi_Notes.pdf" W, H = A4 styles = getSampleStyleSheet() def S(name, parent_name='Normal', **kw): parent = styles[parent_name] return ParagraphStyle(name, parent=parent, **kw) heading1 = S('H1', 'Normal', fontSize=15, leading=20, textColor=colors.HexColor('#1a237e'), fontName='Helvetica-Bold', spaceAfter=4, spaceBefore=10, alignment=TA_CENTER) heading2 = S('H2x', 'Normal', fontSize=13, leading=17, textColor=colors.HexColor('#283593'), fontName='Helvetica-Bold', spaceAfter=3, spaceBefore=8) heading3 = S('H3x', 'Normal', fontSize=11, leading=15, textColor=colors.HexColor('#1565C0'), fontName='Helvetica-Bold', spaceAfter=2, spaceBefore=6) body = S('Bx', 'Normal', fontSize=9.5, leading=14, textColor=colors.HexColor('#212121'), fontName='Helvetica', spaceAfter=4, alignment=TA_JUSTIFY) bullet = S('Bul', 'Normal', fontSize=9.5, leading=14, textColor=colors.HexColor('#212121'), fontName='Helvetica', spaceAfter=3, leftIndent=12) note = S('Nx', 'Normal', fontSize=8.5, leading=12, textColor=colors.HexColor('#6a1515'), fontName='Helvetica-Oblique', spaceAfter=3, leftIndent=6) subtitle = S('STx', 'Normal', fontSize=10, leading=14, textColor=colors.HexColor('#37474f'), fontName='Helvetica-BoldOblique', spaceAfter=2, spaceBefore=4) small = S('Sm', 'Normal', fontSize=8, leading=11, textColor=colors.HexColor('#546e7a'), fontName='Helvetica') CREAM = colors.HexColor('#fffde7') BLUE_LIGHT = colors.HexColor('#e3f2fd') GREEN_LIGHT = colors.HexColor('#e8f5e9') ORANGE_LIGHT = colors.HexColor('#fff3e0') RED_LIGHT = colors.HexColor('#fce4ec') PURPLE_LIGHT = colors.HexColor('#f3e5f5') GREY_LIGHT = colors.HexColor('#f5f5f5') usable_w = W - 3.6*cm def ruled_box(content_list, bg=CREAM, border=colors.HexColor('#bfa060')): t = Table([[c] for c in content_list], colWidths=[usable_w]) t.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,-1), bg), ('BOX', (0,0), (-1,-1), 1.2, border), ('LEFTPADDING', (0,0), (-1,-1), 8), ('RIGHTPADDING', (0,0), (-1,-1), 8), ('TOPPADDING', (0,0), (-1,-1), 4), ('BOTTOMPADDING', (0,0), (-1,-1), 4), ])) return t def two_col_table(data, col1_w=4.2*cm, bg=GREY_LIGHT): col2_w = usable_w - col1_w t = Table(data, colWidths=[col1_w, col2_w]) t.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,0), colors.HexColor('#1a237e')), ('TEXTCOLOR', (0,0), (-1,0), colors.white), ('FONTNAME', (0,0), (-1,0), 'Helvetica-Bold'), ('FONTSIZE', (0,0), (-1,0), 9), ('ROWBACKGROUNDS', (0,1), (-1,-1), [colors.white, bg]), ('FONTNAME', (0,1), (0,-1), 'Helvetica-Bold'), ('FONTSIZE', (0,1), (-1,-1), 8.5), ('LEADING', (0,0), (-1,-1), 13), ('GRID', (0,0), (-1,-1), 0.5, colors.HexColor('#90a4ae')), ('VALIGN', (0,0), (-1,-1), 'TOP'), ('LEFTPADDING', (0,0), (-1,-1), 6), ('RIGHTPADDING', (0,0), (-1,-1), 6), ('TOPPADDING', (0,0), (-1,-1), 4), ('BOTTOMPADDING', (0,0), (-1,-1), 4), ])) return t def three_col_table(data, col_widths, bg=GREY_LIGHT): t = Table(data, colWidths=col_widths) t.setStyle(TableStyle([ ('BACKGROUND', (0,0), (-1,0), colors.HexColor('#283593')), ('TEXTCOLOR', (0,0), (-1,0), colors.white), ('FONTNAME', (0,0), (-1,0), 'Helvetica-Bold'), ('FONTSIZE', (0,0), (-1,0), 8.5), ('ROWBACKGROUNDS', (0,1), (-1,-1), [colors.white, bg]), ('FONTNAME', (0,1), (0,-1), 'Helvetica-Bold'), ('FONTSIZE', (0,1), (-1,-1), 8), ('LEADING', (0,0), (-1,-1), 12), ('GRID', (0,0), (-1,-1), 0.4, colors.HexColor('#90a4ae')), ('VALIGN', (0,0), (-1,-1), 'TOP'), ('LEFTPADDING', (0,0), (-1,-1), 5), ('RIGHTPADDING', (0,0), (-1,-1), 5), ('TOPPADDING', (0,0), (-1,-1), 4), ('BOTTOMPADDING', (0,0), (-1,-1), 4), ])) return t P = Paragraph story = [] # ── COVER ── story += [ Spacer(1, 0.5*cm), P("Pharmacognosy Study Notes — DG-7", heading1), P("Comparative Organoleptic and Macroscopic Evaluation", S('sub2','Normal',fontSize=12,alignment=TA_CENTER,textColor=colors.HexColor('#37474f'),fontName='Helvetica-BoldOblique')), P("Drug 1: Asthishrinkhala | Drug 2: Guduchi", S('sub3','Normal',fontSize=11,alignment=TA_CENTER,textColor=colors.HexColor('#1565C0'),fontName='Helvetica-BoldOblique')), P("Reference: Page 25 | Chapter: Stem Drug Evaluation | With Modern Clinical Correlations and Full Physiological-Pathological Notes", small), HRFlowable(width="100%", thickness=2, color=colors.HexColor('#1a237e'), spaceAfter=8), ] # ═══════════ DRUG 1 ═══════════ story += [P("DRUG 1 — ASTHISHRINKHALA", heading2)] story += [ P("<b>Sanskrit Meaning:</b> 'Asthi' = Bone | 'Shrinkhala' = Chain / Link → Bone Knitter", body), P("<b>Botanical Name:</b> Cissus quadrangularis Linn. (synonym: Vitis quadrangularis Wall.)", body), P("<b>Family:</b> Vitaceae (older texts classify under Liliaceae)", body), P("<b>Common Names:</b> Hadjod (Hindi), Veldt Grape, Devil's Backbone, Harbhanga", body), P("<b>Part Used:</b> Fresh or dried stem — Photo Plate No. 22", body), Spacer(1, 0.15*cm), ] story.append(P("Organoleptic and Macroscopic Characters", heading3)) orgo1 = [ ['Feature', 'Description'], ['Shape', 'FRESH: Fleshy, four-angled and winged stem — most diagnostic macroscopic feature. Leaves constricted at nodes; broadly ovate leaves and spiral tendrils arise from nodes.\nDRIED: Shriveled, twisted pieces with tendrils arising from nodes.'], ['Surface', 'Fresh stem: Deep green\nDry stem: Reddish yellow or dull green'], ['Odour', 'No characteristic odour'], ['Taste', 'Slight sweet taste'], ['Fracture', 'Not separately described; stem is fleshy when fresh'], ['Substitutes and Adulterants', 'No adulterants known. Plant is easily cultivated in gardens — commercially available without significant adulteration risk.'], ] story.append(two_col_table(orgo1, col1_w=4.2*cm, bg=BLUE_LIGHT)) story.append(Spacer(1, 0.2*cm)) story.append(P("Phytochemistry — Active Constituents", heading3)) phyto1 = [ ['Constituent', 'Class and Details'], ['Ketosteroids', 'Anabolic steroid-like compounds — most pharmacologically important; promote osteoblast differentiation from mesenchymal stem cells'], ['Flavonoids', 'Quercetin, Kaempferol — antioxidant and anti-inflammatory'], ['Triterpenoids', 'Beta-sitosterol, Lupeol — anti-inflammatory, anti-osteoclastic'], ['Vitamin C (Ascorbic acid)', 'Essential for collagen synthesis: hydroxylates proline and lysine in pro-collagen chains'], ['Vitamin A', 'Bone mineralization, epithelial tissue integrity'], ['Calcium and Phosphorus salts', 'Direct mineral substrate for bone hydroxyapatite matrix'], ['Stilbene derivatives', 'Resveratrol-type polyphenols — antioxidant, anti-inflammatory'], ['Onocer-7-ene-3a,21b-diol and Onocer-7-ene-3b,21a-diol', 'Unique steroidal molecules from stem; promote regeneration of all connective tissue of mesenchymal origin'], ] story.append(two_col_table(phyto1, col1_w=5.2*cm, bg=GREEN_LIGHT)) story.append(Spacer(1, 0.2*cm)) story.append(P("Pharmacological Actions", heading3)) act1 = [ P("1. Osteogenic and Bone Anabolic Action: Ketosteroids stimulate mesenchymal stem cell differentiation into osteoblasts. Increases Alkaline Phosphatase (ALP), serum calcium, and serum phosphorus. Promotes callus formation. Upregulates Bone Morphogenetic Protein-2 (BMP-2) gene expression.", bullet), P("2. Anti-inflammatory: Inhibits arachidonic acid pathway via Cyclooxygenase (COX) and Lipoxygenase (LOX) inhibition — reduces prostaglandin and leukotriene synthesis.", bullet), P("3. Antioxidant: Flavonoids and Vitamin C scavenge free radicals. Increases Superoxide Dismutase (SOD) activity by approximately 25% (preclinical study data).", bullet), P("4. Gastroprotective: Reduces gastric lesions by approximately 60% in animal models. Counteracts Non-Steroidal Anti-inflammatory Drug (NSAID)-induced gastropathy — clinically important because NSAIDs are often co-prescribed for fracture pain.", bullet), P("5. Anti-osteoporotic: Reduces Parathyroid Hormone (PTH) levels. PTH is elevated in osteoporosis and drives bone resorption through the RANKL (Receptor Activator of Nuclear Factor kappa Beta Ligand) pathway.", bullet), P("6. Metabolic and Anti-obesity: Enhances Glucagon-Like Peptide-1 (GLP-1) secretion and inhibits Dipeptidyl Peptidase-4 (DPP-4) enzyme — improves insulin secretion, reduces appetite. Randomized Controlled Trial 2025 (PMID 41597327).", bullet), P("7. Analgesic: Reduces inflammatory mediators at fracture site, decreasing pain and swelling post-operatively.", bullet), ] story.append(ruled_box(act1, bg=ORANGE_LIGHT, border=colors.HexColor('#e65100'))) story.append(Spacer(1, 0.2*cm)) story.append(P("Clinical Uses — All Dosage Forms with Modern Correlation", heading3)) clin1 = [ ['Dosage Form', 'Preparation and Dose', 'Clinical Use and Modern Evidence'], ['Tablet or Capsule', 'Standardized extract 500 mg to 1 gram orally twice daily', 'Fracture healing, osteoporosis, osteopenia in postmenopausal women. Randomized Controlled Trial 2022 (PMID 35523116): delays bone loss in postmenopausal osteopenia.'], ['Sustained-Release Tablet', '25 milligrams Cissus quadrangularis in 100 milligram Sustained-Release Tablet', 'Increases serum Alkaline Phosphatase, Calcium, and Phosphorus levels. Pilot clinical evidence.'], ['Asthisamharaka Churna (Powder)', 'Equal parts Asthishrinkhala + Arjuna + Godhuma (wheat) + Laksha, mixed with ghee, consumed with milk', 'Bone fracture management (Asthibhanga chikitsa). Classical Ayurvedic formulation.'], ['Asthisamharaka Taila (Medicated oil)', 'Whole plant oil extraction; applied locally over joints', 'Rheumatoid arthritis, osteoarthritis — local anti-inflammatory. Traditional topical use.'], ['Asthishrinkhala Vataka (Tablet)', 'Equal parts: Asthishrinkhala + Black gram flour, formed into tablets', 'Joint-related disorders. Classical formulation.'], ['Lakshaguggulu (Classical tablet)', 'Laksha + Asthishrinkhala + Kakubha + Ashwagandha + Nagabala (equal parts) + Guggulu (5 parts)', 'Bone and joint disorders. Widely used classical polyherbal tablet.'], ['Syrup or Liquid extract', 'Aqueous or ethanolic extract; 10 to 20 milliliters twice daily', 'Wound healing, bleeding associated with bone fractures.'], ['Maxillofacial perioperative capsules', 'Capsules given before and after jaw fracture surgery', 'Reduces pain, swelling, fracture mobility; raises serum Calcium and Phosphorus at day 21. Clinical pilot study (PMC4784127).'], ['Alveolar ridge regeneration supplementation', 'Oral supplementation alongside mandibular distraction osteogenesis procedure', 'Osteogenic support. Randomized Controlled Trial 2021 (PMID 34607598).'], ['GLP-1 Enhancer Supplement', 'Cissus quadrangularis + Dichrostachys glomerata combination capsule', 'Weight management, Glucagon-Like Peptide-1 enhancement, Dipeptidyl Peptidase-4 inhibition in overweight individuals. Randomized Controlled Trial 2025 (PMID 41597327).'], ] cw1 = [3.3*cm, 4.5*cm, usable_w - 3.3*cm - 4.5*cm] story.append(three_col_table(clin1, cw1, bg=BLUE_LIGHT)) story.append(P("2025 Meta-analysis (PMID 40707943): First systematic review and meta-analysis confirming Cissus quadrangularis significantly improves bone mineral density, Parathyroid Hormone, and Alkaline Phosphatase in humans.", note)) story.append(Spacer(1, 0.3*cm)) # ═══════════ DRUG 2 ═══════════ story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#1b5e20'), spaceAfter=6)) story.append(P("DRUG 2 — GUDUCHI (GILOY / AMRITA)", heading2)) story += [ P("<b>Sanskrit Meaning:</b> 'Guduchi' = One that protects the body | 'Amrita' = Nectar of Immortality", body), P("<b>Botanical Name:</b> Tinospora cordifolia (Willd.) Hook. F. and Thoms.", body), P("<b>Family:</b> Menispermaceae", body), P("<b>Common Names:</b> Giloy, Amritavalli, Amrita, Giloe, Gurcha", body), P("<b>Part Used:</b> Dry stem — Photo Plate No. 23", body), Spacer(1, 0.15*cm), ] story.append(P("Organoleptic and Macroscopic Characters", heading3)) orgo2 = [ ['Feature', 'Description'], ['Shape', 'Pieces of dry, cylindrical, soft-wooded stem; diameter 5 millimeters to 25 millimeters'], ['Surface', 'Outer surface: Grayish brown to black; wrinkled longitudinally; warty protuberances and raised lenticels; bark peels off easily as thin papery flakes.\nTransverse section: Soft pale yellow interior; radiating medullary rays with concentric rings — appears as a wheel pattern (key diagnostic feature)'], ['Fracture', 'FIBROUS — important diagnostic character'], ['Odour', 'No characteristic odour'], ['Taste', 'BITTER — key organoleptic hallmark'], ['Substitutes and Adulterants', 'Adulterants:\n1. Thick aerial roots (light grey surface) admixed in commercial samples\n2. Tinospora malabarica (Lam.) Miers — hairy surface; called Kandodbhava Guduchi\n3. Tinospora crispa Hook. F. and Thoms.\nIdentification: Genuine Guduchi has smooth bark peeling in papery flakes; wheel pattern on cross-section; distinctly bitter taste.'], ] story.append(two_col_table(orgo2, col1_w=4.2*cm, bg=GREEN_LIGHT)) story.append(Spacer(1, 0.2*cm)) story.append(P("Phytochemistry — Active Constituents", heading3)) phyto2 = [ ['Constituent Class', 'Key Compounds and Actions'], ['Alkaloids', 'Berberine, Palmatine, Jatrorrhizine, Magnoflorine, Tembetarine — anti-inflammatory, anticancer, antidiabetic'], ['Diterpenoid lactones', 'Tinosporide, Columbin, Tinosporon — hepatoprotective, immunomodulatory'], ['Glycosides', 'Tinosporaside, Cordioside, Syringin — antioxidant, hepatoprotective'], ['Polysaccharides', 'Arabinogalactan polysaccharides — MOST IMPORTANT for immunostimulation; activate macrophages and Natural Killer (NK) cells; bind Pattern Recognition Receptors'], ['Sesquiterpenoids', 'Tinocordifolin, Tinosporaside — anti-inflammatory'], ['Steroids', 'Beta-sitosterol — anti-inflammatory, lipid-lowering'], ['Phenolics', 'Various phenolic acids — antioxidant, anti-microbial'], ['Essential oils and fatty acids', 'Multiple types; contribute to overall bioactivity and bioavailability'], ] story.append(two_col_table(phyto2, col1_w=4.8*cm, bg=PURPLE_LIGHT)) story.append(Spacer(1, 0.2*cm)) story.append(P("Pharmacological Actions", heading3)) act2 = [ P("1. Immunomodulation (Bidirectional — Key Concept): Arabinogalactan polysaccharides bind Pattern Recognition Receptors (Toll-Like Receptors, Mannose Receptors) on macrophages and dendritic cells. Activates innate immunity, increases phagocytic index, enhances Natural Killer cell activity. Acts as STIMULANT when immunity is low (infections) and SUPPRESSANT when overactive (allergies, autoimmune diseases). This bidirectionality is unique.", bullet), P("2. Anti-inflammatory: Berberine inhibits Nuclear Factor kappa Beta (NF-kB) signaling pathway — reduces Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 beta (IL-1b), Interleukin-6 (IL-6). Dual Cyclooxygenase and Lipoxygenase inhibition.", bullet), P("3. Hepatoprotective: Tinosporide protects mitochondria from oxidative injury. Reduces lipid peroxidation. Promotes hepatocyte regeneration. Lowers Aspartate Transaminase (AST) and Alanine Transaminase (ALT) in hepatitis.", bullet), P("4. Antidiabetic: Berberine improves insulin sensitivity via Glucose Transporter-4 (GLUT-4) translocation (similar mechanism to Metformin). Inhibits alpha-glucosidase (similar mechanism to Acarbose). Reduces hepatic glucose output.", bullet), P("5. Antipyretic (Jwarghna — Fever Destroyer): Reduces Prostaglandin E2 in hypothalamus. Validated in Ayurveda for all fevers including dengue, typhoid, viral fevers.", bullet), P("6. Antioxidant: Reduces Reactive Oxygen Species (ROS). Enhances Catalase and Superoxide Dismutase (SOD) activity. Protects cellular membranes from peroxidation.", bullet), P("7. Antineoplastic and Anticancer (Adjuvant): Berberine and Palmatine show cytotoxic activity on cancer cell lines. Arabinogalactan polysaccharides enhance Natural Killer cell and cytotoxic T-cell activity against tumor cells.", bullet), P("8. Adaptogenic and Anti-stress: Acts on Hypothalamic-Pituitary-Adrenal (HPA) axis. Normalizes cortisol levels. Used in chronic stress and adrenal fatigue.", bullet), P("9. Nootropic — Memory and Cognition: Cholinergic modulation; improves Acetylcholine availability. Double-blind Randomized Controlled Trial in healthy volunteers confirmed improved learning and memory.", bullet), P("10. Cardioprotective: Reduces lipid peroxidation in cardiac tissue. Berberine has anti-arrhythmic and cardiotonic properties.", bullet), P("11. Anti-allergic: Modulates Th1/Th2 lymphocyte balance. In allergic states (Th2 dominant), shifts balance toward Th1 — reduces Immunoglobulin E (IgE) production and mast cell degranulation.", bullet), P("12. Anti-anemia of Inflammation: Reduces Hepcidin expression by modulating Interleukin-6 (IL-6). Corrects iron sequestration in inflammatory and chronic disease states. (Scientific Reports, 2019)", bullet), ] story.append(ruled_box(act2, bg=GREEN_LIGHT, border=colors.HexColor('#1b5e20'))) story.append(Spacer(1, 0.2*cm)) story.append(P("Clinical Uses — All Dosage Forms with Modern Correlation", heading3)) clin2 = [ ['Dosage Form', 'Preparation and Dose', 'Clinical Use and Modern Evidence'], ['Ghana Tablet or Capsule', 'Guduchi Ghana standardized extract 500 milligrams twice daily orally', 'Immunostimulation, recurrent infections, dengue fever, COVID-19 support. Randomized Controlled Trial 2023 (PMID 38049897): Tinospora cordifolia with Adhatoda vasica significantly improved clinical and molecular markers in mild COVID-19.'], ['Kwath (Decoction)', 'Stem decoction 20 to 30 milliliters twice daily', 'Chronic fever, malaria adjunct, typhoid, all pyrexias (Jwarghna). Classical and ethnobotanical use.'], ['Sattva (Starch extract)', 'Pure starch from stem; 1 to 3 grams with milk or honey', 'Peptic ulcer, gastritis, hyperacidity, digestive disorders. Most easily absorbed and bioavailable form. Traditional use with preclinical support.'], ['Churna (Powder)', 'Guduchi Churna 3 to 6 grams with honey or ghee twice daily', 'Type 2 Diabetes Mellitus, obesity, liver disease. Validated in multiple preclinical and clinical studies.'], ['Swaras (Fresh stem juice)', 'Fresh stem juice 10 to 20 milliliters on empty stomach daily', 'Hepatitis, jaundice, liver detoxification. Best form for hepatoprotective action.'], ['Syrup and Combination formulas', 'Guduchi + Neem + Tulsi combination syrup; commercial products: Giloy Ghana Vati', 'Fever, dengue, chikungunya, COVID-19 support, general immunity enhancement. Mass-market integrative medicine products.'], ['Guduchyadi Avaleha (Malt)', 'Semi-solid malt formulation taken with warm milk', 'Respiratory allergies, allergic rhinitis. Clinical study (Badar 2004): statistically significant reduction in nasal symptoms, sneezing, and discharge.'], ['Guduchi Ghrita (Medicated ghee)', 'Guduchi-infused clarified butter; 5 to 10 grams with warm milk at bedtime', 'Neurological conditions, memory improvement, cognitive decline, insomnia, Vata-dominant disorders.'], ['Topical lotion', 'Tinospora cordifolia stem extract lotion', 'Scabies management. Andrews Diseases of the Skin textbook: Tinospora lotion appears promising as an alternative treatment for mite infestations.'], ['Injection — Research phase', 'Isolated Arabinogalactan polysaccharide fraction (HARITA) parenteral formulation', 'Immunostimulation in chemotherapy-induced immunosuppression. Research phase only; not yet clinically approved.'], ['Eye drops — Experimental', 'Aqueous stem extract ophthalmic drops', 'Anti-inflammatory in allergic conjunctivitis. Preclinical studies only; not yet standard of care.'], ] cw2 = [3.2*cm, 4.8*cm, usable_w - 3.2*cm - 4.8*cm] story.append(three_col_table(clin2, cw2, bg=GREEN_LIGHT)) story.append(Spacer(1, 0.3*cm)) # ════ PHYSIOLOGY ════ story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#6a1b9a'), spaceAfter=6)) story.append(P("PHYSIOLOGY — MECHANISM OF ACTION IN BODY SYSTEMS", heading2)) story.append(P("A. Physiology of Bone Healing — Relevant to Asthishrinkhala", heading3)) phys1 = [ P("<b>Phase 1 — Haematoma Formation (0 to 72 hours):</b> Blood clot forms at fracture site. Inflammatory cells recruited: neutrophils and macrophages. Cytokines released: Interleukin-1 (IL-1), Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-alpha). Growth factors: Platelet-Derived Growth Factor (PDGF), Fibroblast Growth Factor (FGF), Transforming Growth Factor-beta (TGF-beta).", bullet), P("<b>Phase 2 — Fibrocartilaginous Callus Formation (Day 3 to Day 21):</b> Fibroblasts and chondroblasts differentiate from periosteum. Type II collagen matrix forms. Angiogenesis (new blood vessel formation) occurs. Soft callus bridges the fracture gap.", bullet), P("<b>Phase 3 — Bony Callus Formation (3 weeks to several months):</b> Osteoblasts replace cartilage with woven bone via endochondral ossification. Mineralization with Calcium Hydroxyapatite [Ca10(PO4)6(OH)2]. Serum Alkaline Phosphatase (ALP) rises markedly — clinically measurable.", bullet), P("<b>Phase 4 — Bone Remodeling (Months to Years):</b> Osteoclasts remove woven bone. Osteoblasts lay organized lamellar bone. Haversian systems restored. Controlled by RANKL (Receptor Activator of Nuclear Factor kappa Beta Ligand) and Osteoprotegerin (OPG) axis.", bullet), Spacer(1,0.1*cm), P("<u>How Asthishrinkhala Acts at Each Phase:</u>", subtitle), P("- Ketosteroids push mesenchymal stem cells toward osteoblastic lineage (anabolic action) — more callus formed faster.", bullet), P("- Vitamin C enables hydroxylation of Proline and Lysine in pro-collagen — forms stable Triple-Helix collagen — stronger callus matrix.", bullet), P("- Calcium and Phosphorus salts provide direct mineral substrate for hydroxyapatite deposition.", bullet), P("- Beta-sitosterol reduces inflammation at fracture site (COX and LOX inhibition) — faster transition from inflammatory phase to repair phase.", bullet), P("- Bone Morphogenetic Protein-2 (BMP-2) is upregulated by ketosteroids — BMP-2 is the master transcription regulator of bone formation.", bullet), P("- Net result: Up to 40% improvement in bone healing rate (animal studies); significant elevation of serum ALP, Calcium, and Phosphorus.", bullet), ] story.append(ruled_box(phys1, bg=ORANGE_LIGHT, border=colors.HexColor('#e65100'))) story.append(Spacer(1, 0.25*cm)) story.append(P("B. Physiology of Immunity — Relevant to Guduchi", heading3)) phys2 = [ P("<b>Innate Immunity (Non-specific, First Line):</b> Macrophages, Natural Killer (NK) cells, Dendritic cells, Neutrophils. Pattern Recognition Receptors (Toll-Like Receptors, Mannose Receptors) detect Pathogen-Associated Molecular Patterns (PAMPs). Activation triggers Nuclear Factor kappa Beta (NF-kB) pathway — produces cytokines.", bullet), P("<b>Adaptive Immunity (Specific, Second Line):</b> T Helper cells: Th1 drives cell-mediated immunity against intracellular pathogens; Th2 drives humoral and allergic responses (Immunoglobulin E); Th17 contributes to autoimmunity; T-Regulatory cells suppress immune overactivation. B Lymphocytes produce antibodies (Immunoglobulins).", bullet), Spacer(1,0.1*cm), P("<u>How Guduchi Modulates Immunity:</u>", subtitle), P("- Arabinogalactan polysaccharides bind Mannose Receptors on macrophages — macrophage activation — increased phagocytic index and Interleukin-12 (IL-12) production — stimulates Th1 responses.", bullet), P("- Berberine inhibits Nuclear Factor kappa Beta (NF-kB) — reduces TNF-alpha and IL-1beta in CHRONIC inflammation (auto-regulation of overactive immune states).", bullet), P("- Tinosporaside modulates Th1/Th2 balance: in allergic states (Th2 dominant), shifts toward Th1 — reduces Immunoglobulin E (IgE) production and mast cell degranulation.", bullet), P("- Magnoflorine shows anti-Th17 activity — relevant in autoimmune and inflammatory bowel conditions.", bullet), P("- KEY CLINICAL CONCEPT: Guduchi is a BIDIRECTIONAL immunomodulator — it upregulates immunity when deficient (infections) and downregulates when overactive (allergies, autoimmune diseases). This is pharmacologically unique.", bullet), ] story.append(ruled_box(phys2, bg=PURPLE_LIGHT, border=colors.HexColor('#6a1b9a'))) story.append(Spacer(1, 0.3*cm)) # ════ PATHOLOGY ════ story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#b71c1c'), spaceAfter=6)) story.append(P("PATHOLOGY — DISEASE STATES AND DRUG ROLES", heading2)) story.append(P("A. Pathological Conditions Addressed by Asthishrinkhala", heading3)) path1 = [ ['Disease or Condition', 'Pathological Mechanism', 'Role of Asthishrinkhala'], ['Fractures and Impaired Bone Healing', 'In diabetes, corticosteroid therapy, malnutrition, or elderly: osteoblast activity reduced, osteoclast activity increased — delayed union or non-union of fracture.', 'Ketosteroids restore osteoblastic activity. Vitamin C restores collagen cross-linking. Reduces fracture healing time. Clinical evidence in jaw fractures (PMC4784127).'], ['Osteoporosis', 'Estrogen deficiency post-menopause activates RANKL pathway — osteoclast overactivation — bone mineral density (BMD) loss. Risk of pathological fractures.', 'Reduces Parathyroid Hormone (PTH). Inhibits osteoclast formation. Randomized Controlled Trial 2022 (PMID 35523116): delays bone loss in postmenopausal osteopenia. 2025 Meta-analysis (PMID 40707943) confirms bone biomarker benefit.'], ['Osteoarthritis and Rheumatoid Arthritis', 'Synovial inflammation, cartilage degradation by Matrix Metalloproteinases (MMPs), subchondral bone erosion. Rheumatoid Arthritis: autoimmune TNF-alpha-driven joint destruction.', 'Flavonoids inhibit Matrix Metalloproteinase production, reduce synovial inflammation. Medicated oil (Asthisamharaka Taila) provides local relief.'], ['NSAID-induced Peptic Ulcer', 'NSAIDs inhibit Cyclooxygenase-1 (COX-1) — loss of Prostaglandin E2 — reduced gastric mucus — mucosal erosions.', 'Gastroprotective action: reduces gastric lesions by approximately 60%. Clinically important when NSAIDs are given with CQ for fracture pain management.'], ['Metabolic Syndrome and Obesity', 'Visceral fat adipocytokines increase osteoclast activity — secondary osteoporosis. Insulin resistance worsens bone matrix quality.', 'DPP-4 inhibition and GLP-1 enhancement — improved glucose metabolism, reduced visceral fat, secondary improvement in bone health. Randomized Controlled Trial 2025 (PMID 41597327).'], ] cw_p = [3.6*cm, 5.0*cm, usable_w - 3.6*cm - 5.0*cm] story.append(three_col_table(path1, cw_p, bg=ORANGE_LIGHT)) story.append(Spacer(1, 0.25*cm)) story.append(P("B. Pathological Conditions Addressed by Guduchi", heading3)) path2 = [ ['Disease or Condition', 'Pathological Mechanism', 'Role of Guduchi'], ['Recurrent Infections and Secondary Immunodeficiency', 'Reduced phagocytic activity, low Natural Killer cell count, suppressed T-cell response — impaired pathogen clearance, recurrent bacterial and viral infections.', 'Arabinogalactan polysaccharides restore macrophage phagocytic index and NK cell activity. Increases Interleukin-12 (IL-12) — stimulates Th1 immune response.'], ['Type 2 Diabetes Mellitus', 'Beta-cell dysfunction and peripheral insulin resistance. Hyperglycemia generates Reactive Oxygen Species (ROS) — oxidative tissue damage. Elevated Hemoglobin A1c (HbA1c).', 'Berberine improves insulin sensitivity via GLUT-4 translocation (like Metformin). Alpha-glucosidase inhibition (like Acarbose). Reduces hepatic glucose output. Antioxidant protection of beta cells.'], ['Viral Fevers — Dengue, COVID-19, Chikungunya', 'Cytokine storm: massively elevated IL-6, TNF-alpha, IL-1beta — endothelial damage, thrombocytopenia, multi-organ injury.', 'Randomized Controlled Trial 2023 (PMID 38049897): Tinospora cordifolia + Adhatoda vasica significantly improved clinical and molecular markers in mild COVID-19. NF-kB inhibition modulates cytokine overproduction.'], ['Hepatitis and Drug-Induced Liver Injury', 'Hepatocyte necrosis, elevated AST (Aspartate Transaminase) and ALT (Alanine Transaminase), oxidative mitochondrial stress, Kupffer cell activation.', 'Tinosporide protects mitochondria. Reduces lipid peroxidation. Promotes hepatocyte regeneration. Lowers AST and ALT levels.'], ['Allergic Rhinitis and Bronchial Asthma', 'Immunoglobulin E-mediated Th2 response: IL-4, IL-13 — mast cell sensitization — histamine release — mucosal edema, rhinorrhea, bronchospasm.', 'Shifts Th1/Th2 balance toward Th1. Reduces Immunoglobulin E (IgE) production. Clinical study (Badar 2004): statistically significant improvement in allergic rhinitis.'], ['Anemia of Chronic Inflammation', 'Chronic Interleukin-6 (IL-6) stimulates hepatic Hepcidin production — Hepcidin blocks Ferroportin on enterocytes and macrophages — iron sequestration — functional iron deficiency anemia despite adequate body iron.', 'Guduchi reduces IL-6 and Hepcidin expression — frees iron for erythropoiesis — corrects anemia of chronic disease. (Scientific Reports, 2019)'], ['Cancer — Adjuvant Use in Integrative Oncology', 'Chemotherapy causes bone marrow suppression — neutropenia and immunosuppression — opportunistic infections. Tumor cells evade Natural Killer cell surveillance.', 'Berberine and Palmatine cytotoxic against cancer cell lines. Arabinogalactan polysaccharides restore bone marrow Natural Killer and cytotoxic T-cell function post-chemotherapy. Used as adjuvant.'], ] story.append(three_col_table(path2, cw_p, bg=RED_LIGHT)) story.append(Spacer(1, 0.25*cm)) # ════ ADULTERANT TABLE ════ story.append(HRFlowable(width="100%", thickness=1.5, color=colors.HexColor('#37474f'), spaceAfter=5)) story.append(P("ADULTERANT IDENTIFICATION — QUICK REFERENCE", heading3)) adult = [ ['Drug', 'Genuine Identification Features', 'Common Adulterant', 'Detection Method'], ['Asthishrinkhala\n(Cissus quadrangularis)', 'Four-angled winged fleshy stem; slight sweet taste; deep green (fresh); reddish yellow (dry)', 'None known — plant easily cultivated', 'Confirm four-angled morphology; no significant adulterants'], ['Guduchi\n(Tinospora cordifolia)', 'Cylindrical 5 to 25 mm stem; fibrous fracture; bitter taste; grayish-brown papery peeling bark; wheel pattern on cross-section', '1. Tinospora malabarica — hairy surface (Kandodbhava Guduchi)\n2. Tinospora crispa\n3. Thick aerial roots — light grey', 'Check for hairs (T. malabarica is hairy). Test fracture — genuine is fibrous. Taste must be distinctly bitter. Cross-section must show wheel/radiating medullary ray pattern.'], ] cw_adult = [3*cm, 4.2*cm, 3.8*cm, usable_w - 3*cm - 4.2*cm - 3.8*cm] story.append(three_col_table(adult, cw_adult, bg=GREY_LIGHT)) story.append(Spacer(1, 0.2*cm)) # ════ SUMMARY TABLE ════ story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#1a237e'), spaceAfter=5)) story.append(P("COMPARATIVE SUMMARY — QUICK REVISION TABLE", heading3)) summary = [ ['Parameter', 'Asthishrinkhala (Cissus quadrangularis)', 'Guduchi (Tinospora cordifolia)'], ['Botanical Family', 'Vitaceae (older: Liliaceae)', 'Menispermaceae'], ['Primary Action', 'Bone anabolic and osteogenic', 'Immunomodulatory and adaptogenic'], ['Key Active Constituent', 'Ketosteroids, Vitamin C', 'Berberine, Arabinogalactan polysaccharides'], ['Taste', 'Slight sweet', 'Bitter'], ['Fracture', 'Fleshy (fresh stem)', 'Fibrous (dry stem) — diagnostic'], ['Best Modern Form', 'Tablet, Sustained-Release Tablet, Medicated oil', 'Ghana tablet, Kwath decoction, Sattva (starch)'], ['Primary Mechanism', 'Anabolic bone formation, COX and LOX inhibition, Vitamin C-mediated collagen synthesis, BMP-2 upregulation', 'Macrophage activation, NF-kB inhibition, Th1/Th2 balance, alpha-glucosidase inhibition'], ['Top Modern Evidence', '2025 Meta-analysis — bone biomarkers in humans\nReference PMID 40707943', '2023 Randomized Controlled Trial — COVID-19\nReference PMID 38049897'], ['Safety Note', 'Generally safe. Avoid in pregnancy. Monitor with anti-resorptive drugs.', 'Generally safe. Monitor in patients on biological therapies for autoimmune diseases.'], ['Adulterants', 'None significant', 'Tinospora malabarica (Kandodbhava Guduchi), Tinospora crispa'], ] cw_sum = [4*cm, (usable_w-4*cm)/2, (usable_w-4*cm)/2] story.append(three_col_table(summary, cw_sum, bg=BLUE_LIGHT)) story.append(Spacer(1, 0.2*cm)) # ════ FOOTER ════ story.append(P("Full Forms Reference: ALP = Alkaline Phosphatase | ALT = Alanine Transaminase | AST = Aspartate Transaminase | BMD = Bone Mineral Density | BMP-2 = Bone Morphogenetic Protein-2 | COX = Cyclooxygenase | DPP-4 = Dipeptidyl Peptidase-4 | FGF = Fibroblast Growth Factor | GLP-1 = Glucagon-Like Peptide-1 | GLUT-4 = Glucose Transporter-4 | HbA1c = Hemoglobin A1c | HPA = Hypothalamic-Pituitary-Adrenal | IgE = Immunoglobulin E | IL = Interleukin | LOX = Lipoxygenase | MMP = Matrix Metalloproteinase | NF-kB = Nuclear Factor kappa Beta | NK = Natural Killer | NSAID = Non-Steroidal Anti-inflammatory Drug | OPG = Osteoprotegerin | PDGF = Platelet-Derived Growth Factor | PMID = PubMed Identifier | PTH = Parathyroid Hormone | RANKL = Receptor Activator of Nuclear Factor kappa Beta Ligand | RCT = Randomized Controlled Trial | ROS = Reactive Oxygen Species | SOD = Superoxide Dismutase | TGF-beta = Transforming Growth Factor-beta | TNF-alpha = Tumor Necrosis Factor-alpha", small)) story.append(Spacer(1, 0.15*cm)) story.append(P("References: PMID 40707943 | PMID 35523116 | PMID 34607598 | PMID 41597327 | PMID 38049897 | PMC4784127 | PMC2924974 | Scientific Reports 2019 (Nature) | Andrews Diseases of the Skin E-Book | Badar VA et al., Journal of Ethnopharmacology 2004", small)) doc = SimpleDocTemplate( OUTPUT, pagesize=A4, rightMargin=1.8*cm, leftMargin=1.8*cm, topMargin=2*cm, bottomMargin=2*cm, title="Asthishrinkhala and Guduchi Pharmacognosy Notes", author="DG-7 Study Notes" ) doc.build(story) print("SUCCESS:", OUTPUT) PYEOF

Aloe vera Kumari pharmacology clinical uses phytochemistry modern medicine anthraquinone mechanism

Gymnema sylvestre antidiabetic mechanism clinical

Adhatoda vasica bronchial asthma respiratory vasicine clinical

Aloe vera wound healing anti-inflammatory clinical trial

Gymnema sylvestre Meshashringi pharmacology gymnemic acid antidiabetic taste suppression mechanism Adhatoda vasica vasicine bronchodilator modern clinical

python3 << 'PYEOF' from reportlab.lib.pagesizes import A4 from reportlab.lib import colors from reportlab.lib.units import cm from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle from reportlab.platypus import SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle, HRFlowable from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY OUTPUT = "/tmp/workspace/ayurveda-notes/Kumari_Meshashringi_Vaasa_Notes.pdf" W, H = A4 styles = getSampleStyleSheet() def S(name, parent_name='Normal', **kw): return ParagraphStyle(name, parent=styles[parent_name], **kw) H1 = S('H1x', fontSize=15, leading=20, textColor=colors.HexColor('#1a237e'), fontName='Helvetica-Bold', spaceAfter=4, spaceBefore=6, alignment=TA_CENTER) H2 = S('H2x', fontSize=13, leading=17, textColor=colors.HexColor('#283593'), fontName='Helvetica-Bold', spaceAfter=3, spaceBefore=8) H3 = S('H3x', fontSize=11, leading=15, textColor=colors.HexColor('#1565C0'), fontName='Helvetica-Bold', spaceAfter=2, spaceBefore=6) BD = S('BDx', fontSize=9.5, leading=14, textColor=colors.HexColor('#212121'), fontName='Helvetica', spaceAfter=4, alignment=TA_JUSTIFY) BL = S('BLx', fontSize=9.2, leading=13.5, textColor=colors.HexColor('#212121'), fontName='Helvetica', spaceAfter=3, leftIndent=10) NT = S('NTx', fontSize=8.5, leading=12, textColor=colors.HexColor('#6a1515'), fontName='Helvetica-Oblique', spaceAfter=3, leftIndent=6) ST = S('STx', fontSize=10, leading=14, textColor=colors.HexColor('#37474f'), fontName='Helvetica-BoldOblique', spaceAfter=2, spaceBefore=4) SM = S('SMx', fontSize=8, leading=11, textColor=colors.HexColor('#546e7a'), fontName='Helvetica') CREAM = colors.HexColor('#fffde7') BLUE = colors.HexColor('#e3f2fd') GREEN = colors.HexColor('#e8f5e9') ORANGE = colors.HexColor('#fff3e0') RED = colors.HexColor('#fce4ec') PURPLE = colors.HexColor('#f3e5f5') GREY = colors.HexColor('#f5f5f5') TEAL = colors.HexColor('#e0f7fa') usable_w = W - 3.6*cm def box(rows, bg=CREAM, border=colors.HexColor('#bfa060')): t = Table([[r] for r in rows], colWidths=[usable_w]) t.setStyle(TableStyle([ ('BACKGROUND',(0,0),(-1,-1),bg), ('BOX',(0,0),(-1,-1),1.2,border), ('LEFTPADDING',(0,0),(-1,-1),8),('RIGHTPADDING',(0,0),(-1,-1),8), ('TOPPADDING',(0,0),(-1,-1),4),('BOTTOMPADDING',(0,0),(-1,-1),4), ])) return t def t2(data, c1=4.2*cm, bg=GREY): c2 = usable_w - c1 t = Table(data, colWidths=[c1, c2]) t.setStyle(TableStyle([ ('BACKGROUND',(0,0),(-1,0),colors.HexColor('#1a237e')), ('TEXTCOLOR',(0,0),(-1,0),colors.white),('FONTNAME',(0,0),(-1,0),'Helvetica-Bold'), ('FONTSIZE',(0,0),(-1,0),9), ('ROWBACKGROUNDS',(0,1),(-1,-1),[colors.white,bg]), ('FONTNAME',(0,1),(0,-1),'Helvetica-Bold'),('FONTSIZE',(0,1),(-1,-1),8.5), ('LEADING',(0,0),(-1,-1),13),('GRID',(0,0),(-1,-1),0.5,colors.HexColor('#90a4ae')), ('VALIGN',(0,0),(-1,-1),'TOP'), ('LEFTPADDING',(0,0),(-1,-1),6),('RIGHTPADDING',(0,0),(-1,-1),6), ('TOPPADDING',(0,0),(-1,-1),4),('BOTTOMPADDING',(0,0),(-1,-1),4), ])) return t def t3(data, cws, bg=GREY): t = Table(data, colWidths=cws) t.setStyle(TableStyle([ ('BACKGROUND',(0,0),(-1,0),colors.HexColor('#283593')), ('TEXTCOLOR',(0,0),(-1,0),colors.white),('FONTNAME',(0,0),(-1,0),'Helvetica-Bold'), ('FONTSIZE',(0,0),(-1,0),8.5), ('ROWBACKGROUNDS',(0,1),(-1,-1),[colors.white,bg]), ('FONTNAME',(0,1),(0,-1),'Helvetica-Bold'),('FONTSIZE',(0,1),(-1,-1),8), ('LEADING',(0,0),(-1,-1),12),('GRID',(0,0),(-1,-1),0.4,colors.HexColor('#90a4ae')), ('VALIGN',(0,0),(-1,-1),'TOP'), ('LEFTPADDING',(0,0),(-1,-1),5),('RIGHTPADDING',(0,0),(-1,-1),5), ('TOPPADDING',(0,0),(-1,-1),4),('BOTTOMPADDING',(0,0),(-1,-1),4), ])) return t P = Paragraph story = [] # ── COVER ── story += [ Spacer(1,0.4*cm), P("Pharmacognosy Study Notes — DG-7",H1), P("Comparative Organoleptic and Macroscopic Evaluation — Leaf and Juice Drugs", S('s2','Normal',fontSize=12,alignment=TA_CENTER,textColor=colors.HexColor('#37474f'),fontName='Helvetica-BoldOblique')), P("Drug 1: Kumari (Aloe vera) | Drug 2: Meshashringi (Gymnema sylvestre) | Drug 3: Vaasa (Adhatoda vasica)", S('s3','Normal',fontSize=10,alignment=TA_CENTER,textColor=colors.HexColor('#1565C0'),fontName='Helvetica-BoldOblique')), P("Reference: Pages 29-30 | Handbook on Dravyaguna: Practical Manual | Photo Plates 32-34 | With Modern Clinical Correlations, Full Physiology and Pathology Notes",SM), HRFlowable(width="100%",thickness=2,color=colors.HexColor('#1a237e'),spaceAfter=8), ] #══════════════════════════════════════════════ # DRUG 1 — KUMARI #══════════════════════════════════════════════ story += [P("DRUG 1 — KUMARI",H2)] story += [ P("<b>Sanskrit Meaning:</b> 'Kumari' = Young girl / Virgin — refers to the plant's regenerative and youth-restoring properties",BD), P("<b>Botanical Name:</b> Aloe vera (Linn.) Burn. F. synonym Aloe barbadensis Mill. and other Aloe species",BD), P("<b>Family:</b> Liliaceae (modern: Xanthorrhoeaceae / Asphodelaceae)",BD), P("<b>Common Names:</b> Ghritkumari, Aloe, Burn Plant, Ghee Kunwar, Kathalai (Tamil)",BD), P("<b>Part Used:</b> Fresh and dried juice obtained from leaves (Photo Plate No. 32)",BD), P("<b>Drug Form:</b> The commercially available drug is the inspissated (concentrated and dried) leaf juice — called 'Musabbar' or 'Aloes' in Unani medicine",BD), Spacer(1,0.15*cm), ] story.append(P("Organoleptic and Macroscopic Characters",H3)) orgo1 = [ ['Feature','Description'], ['Shape','Solid mass available in irregular shapes and different sizes. Represents dried and inspissated leaf exudate (latex layer below the outer green rind).'], ['Surface','OLD DRIED MASS: Dark brown to black; hard and opaque surface.\nFRESH MATERIAL: Sticky surface; pieces are thin, translucent and brownish.'], ['Fracture','BRITTLE — important diagnostic character of the dried inspissated juice'], ['Odour','Disagreeable, nauseating — due to anthraquinone glycosides (Aloin, Barbaloin)'], ['Taste','Bitter — due to anthraquinone content'], ['Substitutes and Adulterants','ADULTERANTS: Black catechu, dust, or sand (common in market samples).\nVARIETIES OF ALOE AVAILABLE:\n1. Curacao Aloe (Aloe barbadensis) — Yellowish brown colour\n2. Cape Aloe (Aloe ferox) — Greenish brown colour\n3. Socotrine Aloe (Aloe perryi) — Dark brown with glossy texture\n4. Zingiber Aloe — Light blue colour\nIMPORTANT NOTE: The drug on page refers to the JUICE/LATEX form, distinct from the inner gel (Aloe vera gel used in cosmetics and topical applications).'], ] story.append(t2(orgo1,c1=4.2*cm,bg=BLUE)) story.append(Spacer(1,0.2*cm)) story.append(P("Phytochemistry — Active Constituents",H3)) phyto1 = [ ['Constituent Class','Key Compounds and Pharmacological Role'], ['Anthraquinone glycosides','Aloin (Barbaloin), Aloe-emodin, Emodin, Rhein — MOST IMPORTANT. Responsible for purgative/laxative action. Aloin is the main component of the DRIED LATEX. Irritates large intestinal mucosa.'], ['Polysaccharides','Acemannan (Acetylated mannose polymer) — immunostimulant, wound healing, antiviral (HIV). Found mainly in the GEL (inner layer).'], ['Chromone glycosides','Aloesin, Aloeresin A and B — anti-inflammatory, inhibit prostaglandin synthesis'], ['Flavonoids','Quercetin, Apigenin, Kaempferol — antioxidant, anti-inflammatory'], ['Vitamins','Vitamins A (Beta-carotene), C (Ascorbic acid), E (Tocopherol), B12, Folic acid — skin healing, antioxidant'], ['Minerals','Calcium, Magnesium, Zinc, Selenium, Manganese — enzyme cofactors, wound healing'], ['Amino acids','20 amino acids including 8 essential amino acids — tissue repair'], ['Enzymes','Superoxide Dismutase (SOD), Catalase, Lipase, Amylase, Bradykinase — anti-inflammatory (Bradykinase reduces erythema)'], ['Salicylic acid','Anti-inflammatory, analgesic — contributes to topical anti-inflammatory action'], ['Sterols','Beta-sitosterol, Campesterol, Lupeol — anti-inflammatory, cholesterol-lowering'], ] story.append(t2(phyto1,c1=5.0*cm,bg=GREEN)) story.append(Spacer(1,0.2*cm)) story.append(P("Pharmacological Actions",H3)) act1 = [ P("1. Laxative and Purgative Action: Anthraquinones (Aloin/Barbaloin) stimulate large intestinal mucosa — increase intestinal motility and colonic secretions — peristaltic contractions. Small dose: digestive tonic (improves intestinal muscle tone). Large dose: strong cathartic/purgative (stimulant laxative).", BL), P("2. Wound Healing and Skin Regenerative Action: Acemannan stimulates fibroblast proliferation, increases collagen synthesis, promotes epithelialization. Moisturizes dermis, maintains skin hydration. Meta-analysis 2024 (PMID 38605441): Aloe vera significantly accelerates burn wound healing and reduces pain in burns.", BL), P("3. Anti-inflammatory: Bradykinase enzyme in gel reduces erythema and inflammation. Aloesin inhibits prostaglandin synthesis. Reduces Thromboxane B2 and Prostaglandin E2 production. Salicylic acid adds topical anti-inflammatory activity.", BL), P("4. Antidiabetic: Reduces fasting blood glucose by improving insulin sensitivity, inhibiting alpha-glucosidase, reducing hepatic glucose output. Lowers HbA1c (Glycated Hemoglobin). Randomized Controlled Trial 2024 (PMID 37670716): Aloe vera gel accelerated diabetic foot ulcer healing.", BL), P("5. Hepatoprotective: Protects hepatocytes from oxidative injury. Reduces liver enzyme elevation (AST/ALT). Antioxidant enzymes (SOD, Catalase) scavenge Reactive Oxygen Species in liver tissue.", BL), P("6. Immunomodulatory: Acemannan activates macrophages, increases Natural Killer (NK) cell activity, stimulates Interleukin-1 (IL-1) and Tumor Necrosis Factor-alpha (TNF-alpha). Potential antiviral against HIV (studied in research).", BL), P("7. Cardioprotective and Anti-atheromatous: Reduces total serum cholesterol, serum triglycerides, Low-Density Lipoprotein (LDL). Raises High-Density Lipoprotein (HDL). Clinical study of 5000 patients with atheromatous heart disease: Isabgol + Aloe vera reduced anginal attacks and allowed tapering of verapamil, nifedipine, beta-blockers, and nitrates.", BL), P("8. Anticancer (Research Phase): Aloe-emodin and anthraquinones induce apoptosis (programmed cell death) in cancer cell lines — inhibit tumor growth. Anthraquinones reviewed as potential modulators of inflammaging in autoimmune and onco-hematological diseases (MDPI Molecules 2025).", BL), P("9. Antifungal and Antimicrobial: Anthraquinones inhibit bacterial cell wall synthesis. Effective against Staphylococcus aureus, Candida albicans, Streptococcus species.", BL), P("10. Gastroprotective: Aloe vera gel inhibits excessive secretion of Hydrochloric acid (HCl), promotes protein digestion, reduces bacterial putrefaction in intestine. Used for peptic ulcer and Irritable Bowel Syndrome.", BL), ] story.append(box(act1, bg=ORANGE, border=colors.HexColor('#e65100'))) story.append(Spacer(1,0.2*cm)) story.append(P("Clinical Uses — All Dosage Forms with Modern Correlation",H3)) clin1 = [ ['Dosage Form','Preparation and Dose','Clinical Use and Evidence'], ['Gel (Topical)','Fresh inner leaf gel applied directly; commercial 99% Aloe vera gel', 'Burns (1st and 2nd degree), sunburn, radiation dermatitis, psoriasis, wound healing, acne, diabetic foot ulcer. Meta-analysis 2024 (PMID 38605441): significantly accelerates burn healing and reduces pain. RCT 2024 (PMID 37670716): diabetic foot ulcer healing.'], ['Juice (Oral)','Aloe vera juice 15 to 30 milliliters twice daily before meals', 'Peptic ulcer, gastritis, Irritable Bowel Syndrome, constipation, diabetes management, cardiovascular protection.'], ['Tablet or Capsule','Standardized Aloe extract 500 milligrams to 1 gram', 'Constipation, diabetes adjunct, immune support, metabolic syndrome.'], ['Latex (Cathartic)','Dried latex inspissated drug (the page drug); 50 to 200 milligrams', 'Stimulant laxative for constipation. Caution: avoid in pregnancy (uterine stimulant), IBD, hemorrhoids.'], ['Churna (Ayurvedic powder)','Kumari Churna 3 to 6 grams with warm water or ghee', 'Liver detox, digestive disorders, menstrual irregularities (Raktapitta), amenorrhea.'], ['Kwath (Decoction)','Leaf decoction 20 to 30 milliliters', 'Liver disorders, anemia, skin diseases.'], ['Kumaryasava (Fermented preparation)','Classical Ayurvedic fermented preparation with Kumari as base', 'Liver diseases, digestive weakness, anemia, menstrual disorders. Contains natural alcohol as preservative and bioavailability enhancer.'], ['Topical cream or lotion','Aloe vera extract 0.5% in cream base', 'Psoriasis vulgaris (double-blind Randomized Controlled Trial), seborrheic dermatitis, contact dermatitis.'], ['Mouthwash or gel','Aloe vera 50% mouthwash', 'Oral mucositis from chemotherapy/radiotherapy, aphthous ulcers, plaque reduction — clinical trials support efficacy.'], ['Wound dressing','Aloe vera impregnated dressing', 'Pressure ulcer pain reduction (Randomized Controlled Trial 2024 PMID 38229162), chronic wound management.'], ] cw1 = [3.2*cm, 4.5*cm, usable_w-3.2*cm-4.5*cm] story.append(t3(clin1,cw1,bg=BLUE)) story.append(P("2024 Meta-analysis (PMID 38605441): Aloe vera significantly reduces burn wound healing time, decreases pain, and lowers infection risk in first- and second-degree burns. 2022 Meta-analysis (PMID 36264753): confirms benefit in second-degree burns.", NT)) story.append(Spacer(1,0.3*cm)) #══════════════════════════════════════════════ # DRUG 2 — MESHASHRINGI #══════════════════════════════════════════════ story.append(HRFlowable(width="100%",thickness=2,color=colors.HexColor('#1b5e20'),spaceAfter=6)) story.append(P("DRUG 2 — MESHASHRINGI (GURMAR)",H2)) story += [ P("<b>Sanskrit Meaning:</b> 'Mesha' = Sheep/Ram | 'Shringi' = Horn/Horned → Ram's Horn (refers to leaf shape). Hindi name 'Gurmar' = 'Gur' (Jaggery) + 'Mar' (Killer) = Sugar Destroyer",BD), P("<b>Botanical Name:</b> Gymnema sylvestre R.Br.",BD), P("<b>Family:</b> Asclepiadaceae (modern: Apocynaceae)",BD), P("<b>Common Names:</b> Gurmar, Madhunashini (Sugar Destroyer), Periploca of the Woods",BD), P("<b>Part Used:</b> Dried leaf (Photo Plate No. 33)",BD), Spacer(1,0.15*cm), ] story.append(P("Organoleptic and Macroscopic Characters",H3)) orgo2 = [ ['Feature','Description'], ['Shape','Simple opposite leaves; shape ovate or elliptic; petioles present and are pubescent (hairy). Leaf blade 3 to 6 centimeters long and 1 to 3 centimeters broad; acute apex; pubescent on both sides; base rounded or cordate; venation is reticulate (net-like veins).'], ['Odour','Unpleasant'], ['Taste','Bitter — and critically: MAKES THE SWEET TASTE IMPERCEPTIBLE. After chewing or keeping in mouth, all sweet substances lose their sweetness temporarily. This is the PATHOGNOMONIC diagnostic feature of Meshashringi.'], ['Substitutes and Adulterants','Not specifically detailed in the page. Commonly related species used as substitutes. Gymnema montanum is a common adulterant with similar morphology.'], ] story.append(t2(orgo2,c1=4.2*cm,bg=GREEN)) story.append(Spacer(1,0.2*cm)) story.append(P("Phytochemistry — Active Constituents",H3)) phyto2 = [ ['Constituent Class','Key Compounds and Actions'], ['Gymnemic acids (Triterpenoid saponins)','MOST IMPORTANT. Mixture of triterpene saponins — Gymnemic Acid I through VIII and beyond. Structurally similar to glucose. Responsible for: (1) sweet taste suppression, (2) inhibition of intestinal glucose absorption, (3) alpha-glucosidase inhibition. Main antidiabetic agents.'], ['Gurmarin (Polypeptide)','44-amino acid polypeptide. Blocks T1R2/T1R3 sweet taste receptor complex in humans and animals. Strongest sweet taste blocker — effects last more than 10 minutes.'], ['Gymnemasaponins','Additional saponins with antidiabetic and lipid-lowering effects'], ['Conduritol A','Cyclitol — inhibits glucose absorption in intestinal brush border'], ['Flavonoids','Quercetin, Luteolin — antioxidant, anti-inflammatory'], ['Alkaloids','Tartaric acid, Formic acid, Butyric acid — antimicrobial'], ['Sterols','Beta-sitosterol, Stigmasterol — lipid-lowering'], ['Tannins','Astringent, antimicrobial'], ['Amino acids','Alanine, Glycine, Leucine — metabolic support'], ] story.append(t2(phyto2,c1=5.2*cm,bg=PURPLE)) story.append(Spacer(1,0.2*cm)) story.append(P("Pharmacological Actions",H3)) act2 = [ P("1. Sweet Taste Suppression (Antisweet Activity — Unique): Gymnemic acids and Gurmarin competitively block T1R2/T1R3 sweet taste receptor complex (heterodimer) in taste buds. Steric blocking of receptor — sweetness of sugar, artificial sweeteners (including Aspartame and Saccharin), and natural sweeteners (including Thaumatin) becomes imperceptible. Effect is REVERSIBLE — lasts 10 to 45 minutes. Randomized Controlled Trial 2025 (PMID 40944109): reduces motivation to consume sweet foods.", BL), P("2. Antidiabetic — Multiple Mechanisms: (a) Intestinal glucose absorption inhibition: Gymnemic acids block intestinal glucose transporter sites — similar structure to glucose — competitive inhibition. (b) Alpha-glucosidase inhibition: Prevents hydrolysis of disaccharides in intestinal brush border — reduces postprandial glucose spike (similar to Acarbose). (c) Beta-cell regeneration: Gymnemic acids promote regeneration of insulin-secreting beta cells in Islets of Langerhans in pancreas. (d) Insulin secretagogue: Stimulates insulin secretion from remaining beta cells. Systematic Review and Meta-analysis 2021 (PMID 34467577): Gymnema sylvestre significantly reduces fasting blood glucose and HbA1c in Type 2 Diabetes Mellitus patients. Randomized Controlled Trial 2021 (PMID 32460589): improves glycemic control, insulin secretion, and insulin sensitivity in impaired glucose tolerance.", BL), P("3. Anti-obesity and Appetite Suppression: By blocking sweet taste receptors, reduces craving for sweets and sugary foods. Randomized Controlled Trial 14-day intervention (PMID 36558446): significantly reduces sugar cravings and sugar intake. Helps reduce caloric intake and body weight.", BL), P("4. Lipid-Lowering (Hypolipidemic): Reduces total cholesterol, Low-Density Lipoprotein (LDL), Very Low-Density Lipoprotein (VLDL), and triglycerides. Raises High-Density Lipoprotein (HDL). Mechanism: inhibits lipid absorption in intestine and increases lipid metabolism in liver.", BL), P("5. Antioxidant and Anti-inflammatory: Flavonoids and gymnemic acids scavenge Reactive Oxygen Species (ROS). Inhibit Nuclear Factor kappa Beta (NF-kB) — reduce Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-6 (IL-6). Protects pancreatic beta cells from oxidative damage.", BL), P("6. Antimicrobial: Alkaloids and tannins inhibit growth of Staphylococcus aureus, Escherichia coli, Bacillus subtilis, Salmonella species.", BL), P("7. Diuretic: Traditional use; increases urine output; assists in kidney function and edema management.", BL), P("8. Cardioprotective: Lipid-lowering and anti-inflammatory effects reduce cardiovascular risk. Used in metabolic syndrome and diabetic dyslipidemia.", BL), P("9. Anti-caries and Oral Health: Reduces Streptococcus mutans biofilm formation in dental caries. Reduces sugar availability at tooth surface (sweet taste blocking reduces sugar intake).", BL), ] story.append(box(act2,bg=TEAL,border=colors.HexColor('#006064'))) story.append(Spacer(1,0.2*cm)) story.append(P("Clinical Uses — All Dosage Forms with Modern Correlation",H3)) clin2 = [ ['Dosage Form','Preparation and Dose','Clinical Use and Evidence'], ['Tablet or Capsule','Gymnema sylvestre extract 400 to 800 milligrams (standardized to 25% gymnemic acids) per day', 'Type 2 Diabetes Mellitus: reduces HbA1c (Glycated Hemoglobin) and fasting blood glucose. Meta-analysis 2021 (PMID 34467577) confirms significant glycemic improvement. Metabolic syndrome.'], ['Churna (Powder)','Meshashringi Churna 3 to 6 grams with warm water before meals', 'Prediabetes (impaired glucose tolerance), Type 2 Diabetes, obesity, lipid disorders. Randomized Controlled Trial 2021 (PMID 32460589).'], ['Kwath (Decoction)','20 to 30 milliliters of leaf decoction twice daily', 'Diabetes adjunct therapy, liver disorders, fever management.'], ['Leaf Chewing / Lozenges','Fresh or dried leaf chewed before meals; or lozenge formulation', 'Immediate sweet taste blocking — reduces desire for sweets, controls postprandial glucose spikes. Randomized Controlled Trial 2025 (PMID 40944109): reduces motivation to eat sweet foods. Randomized Controlled Trial 2022 (PMID 36558446): 14-day intervention reduces sugar cravings significantly.'], ['Sugar Craving Supplement','Gymnema sylvestre 75 (75% gymnemic acid extract) capsule; 100 to 200 milligrams', 'Obesity management, sugar addiction, caloric restriction support. Also used in soft drinks, tea bags, energy supplements as food industry functional ingredient.'], ['Combined Antidiabetic Formulation','Meshashringi + Karela (Bitter gourd) + Jamun seed combination', 'Synergistic antidiabetic action — multiple mechanisms targeting different steps of glucose metabolism.'], ['Nanoformulation (Research)','Gymnemic acid nanoparticles for improved solubility and bioavailability', 'Research phase — addresses poor water solubility limitation of gymnemic acid. Superior glucose lowering shown in preclinical studies.'], ['Topical preparation','Leaf extract cream or gel', 'Anti-inflammatory for skin conditions, antimicrobial for wound care.'], ] cw2 = [3.2*cm, 4.5*cm, usable_w-3.2*cm-4.5*cm] story.append(t3(clin2,cw2,bg=TEAL)) story.append(Spacer(1,0.3*cm)) #══════════════════════════════════════════════ # DRUG 3 — VAASA #══════════════════════════════════════════════ story.append(HRFlowable(width="100%",thickness=2,color=colors.HexColor('#4a148c'),spaceAfter=6)) story.append(P("DRUG 3 — VAASA (MALABAR NUT)",H2)) story += [ P("<b>Sanskrit Meaning:</b> 'Vaasa' or 'Vasa' = One who lives/dwells — refers to the plant's widespread distribution. Also called 'Adusha' = Goat's food resistant (goats avoid it due to bitter taste)",BD), P("<b>Botanical Name:</b> Adhatoda Medik synonym Adhatoda vasica Nees.",BD), P("<b>Family:</b> Acanthaceae",BD), P("<b>Common Names:</b> Malabar Nut, Arusa, Adusha, Adulsa, Pavettai (Tamil), Adusa",BD), P("<b>Part Used:</b> Leaves and terminal leafy branches (Photo Plate No. 34)",BD), Spacer(1,0.15*cm), ] story.append(P("Organoleptic and Macroscopic Characters",H3)) orgo3 = [ ['Feature','Description'], ['Shape','Entire leaf; shape LANCEOLATE with pointed tip/apex. Lamina: 12 to 20 centimeters long, 2.5 to 5 centimeters broad; with a long petiole. Dry leaves: brittle and available as small pieces of brownish green colour.'], ['Surface','Upper surface: GLABROUS (smooth, without hairs), dark green. Lower surface: paler, slightly hairy.'], ['Fracture','BRITTLE in dried state — important diagnostic character'], ['Odour','CHARACTERISTIC — due to vasicine alkaloid content. Distinctly recognizable odour.'], ['Taste','BITTER — due to quinazoline alkaloids'], ['Substitutes and Adulterants','ADMIXTURES: Twigs or inflorescence (spikes) mixed in commercial samples.\nSUBSTITUTE: Adhatoda beddomi C-B Clarke used as substitute.\nAVAILABILITY: Plant grows commonly throughout India as a fencing plant — widely available, not usually adulterated significantly.\nIMPORTANT: Only LEAVES to be used; twigs and inflorescence represent adulteration.'], ] story.append(t2(orgo3,c1=4.2*cm,bg=PURPLE)) story.append(Spacer(1,0.2*cm)) story.append(P("Phytochemistry — Active Constituents",H3)) phyto3 = [ ['Constituent Class','Key Compounds and Actions'], ['Quinazoline alkaloids','MOST IMPORTANT. Vasicine (Peganine) — primary alkaloid (0.5-1%). Vasicinone — oxidation product of Vasicine. Vasicinol — pharmacologically active derivative. Deoxyvasicine — antispasmodic. Responsible for all broncho-pharmacological actions.'], ['Vasicine derivatives (Synthetic analogs)','Bromhexine hydrochloride — synthetic derivative of Vasicine. Most widely used mucolytic in modern medicine. Ambroxol — active metabolite of Bromhexine. BOTH are in every pharmacy worldwide as over-the-counter drugs.'], ['Essential oils','Vasakine, Adhatodic acid, Quinazoline derivatives — contribute to characteristic odour and antimicrobial activity'], ['Triterpenoids','Lupeol, Oleanolic acid, Ursolic acid — anti-inflammatory'], ['Tannins','Condensed tannins — astringent, haemostatic'], ['Steroids','Beta-sitosterol — anti-inflammatory'], ['Phenolics','Various phenolic acids — antioxidant, antimicrobial'], ] story.append(t2(phyto3,c1=5.0*cm,bg=PURPLE)) story.append(Spacer(1,0.2*cm)) story.append(P("Pharmacological Actions",H3)) act3 = [ P("1. Bronchodilatory Action (MOST IMPORTANT — unique to Vaasa): Vasicine acts on bronchial smooth muscle — direct bronchodilation by relaxing airway smooth muscle. Mechanism: Phosphodiesterase (PDE) inhibition — increases cyclic Adenosine Monophosphate (cAMP) in bronchial smooth muscle — bronchodilation. Vasicine also stimulates beta-2 adrenergic-like receptor activity.", BL), P("2. Mucolytic / Expectorant: Vasicine stimulates bronchial mucosal secretions — liquefies thick viscid mucus — makes expectoration easier. MODERN DRUG CONNECTION: Bromhexine HCl (Bisolvon) and Ambroxol (Ambrodil, Mucosolvan) are direct synthetic derivatives of Vasicine. HALF the world's mucolytics are derived from Vasicine. Increases Surfactant production from type II pneumocytes.", BL), P("3. Anti-asthmatic: Dual action — bronchodilation + reduction of mucus plugging. Reduces bronchial hyperreactivity. Traditional use in bronchial asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis. Randomized Controlled Trial 2023 (PMID 38049897): Adhatoda vasica + Tinospora cordifolia combination improved clinical and molecular markers in mild COVID-19 — reduced respiratory symptoms.", BL), P("4. Anti-inflammatory (Respiratory): Vasicine and Vasicinone inhibit Cyclooxygenase (COX) and Lipoxygenase (LOX) — reduce Leukotriene B4 (LTB4) and Prostaglandin E2 (PGE2) production — key mediators of airway inflammation in asthma.", BL), P("5. Antibacterial and Antimycobacterial: Vasicine and essential oils inhibit Mycobacterium tuberculosis growth. Traditionally used as adjunct in tuberculosis treatment. Active against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae.", BL), P("6. Uterotonic and Oxytocic: Vasicine causes uterine smooth muscle contraction — used traditionally to induce labor and for post-partum haemorrhage. CAUTION: CONTRAINDICATED in pregnancy — abortifacient at high doses.", BL), P("7. Antifungal: Active against Candida albicans and Aspergillus species.", BL), P("8. Antipyretic: Reduces fever by central hypothalamic action — prostaglandin inhibition at thermoregulatory center.", BL), P("9. Antiulcer: Leaf extract reduces gastric mucosal damage — protects against NSAID-induced gastric erosions.", BL), ] story.append(box(act3,bg=PURPLE,border=colors.HexColor('#4a148c'))) story.append(Spacer(1,0.2*cm)) story.append(P("Clinical Uses — All Dosage Forms with Modern Correlation",H3)) clin3 = [ ['Dosage Form','Preparation and Dose','Clinical Use and Evidence'], ['Vaasa Kwath (Decoction)','15 to 30 milliliters of leaf decoction twice daily; can add honey or ginger', 'Bronchial asthma, chronic cough, bronchitis, COPD adjunct. Most common traditional form.'], ['Vaasa Churna (Leaf powder)','3 to 6 grams powder with honey twice daily', 'Respiratory infections, pulmonary tuberculosis adjunct, chronic obstructive pulmonary disease.'], ['Vaasa Swaras (Fresh juice)','10 to 20 milliliters with honey; given in cold and cough', 'Acute bronchitis, whooping cough, haemoptysis (spitting blood). Best form for immediate expectorant action.'], ['Vaasarishta (Fermented preparation)','15 to 30 milliliters after meals twice daily', 'Chronic respiratory disorders, tuberculosis, asthma, debility. Classical Ayurvedic fermented formulation.'], ['Vasa Ghrita (Medicated ghee)','5 to 10 grams with warm milk', 'Chronic respiratory diseases, haemoptysis, pitta disorders.'], ['Commercial Bromhexine HCl tablets','Bromhexine 8 milligrams, 3 times daily (Synthetic derivative of Vasicine)', 'GLOBAL PHARMACEUTICAL STANDARD for mucolytic therapy. Acute and chronic bronchitis, COPD, asthma mucus clearance, sinusitis. Most widely prescribed mucolytic worldwide. DIRECTLY DERIVED FROM VASICINE.'], ['Ambroxol tablets or syrup','Ambroxol 30 to 60 milligrams (active metabolite of Bromhexine)', 'Respiratory distress syndrome (neonates — stimulates surfactant production), bronchitis, post-operative pulmonary atelectasis prevention, COPD maintenance. More potent than Bromhexine.'], ['Combination syrup','Vaasa + Tulsi + Adrak (ginger) + Mulethi (liquorice) combinations; commercial syrups', 'Cough and cold management, paediatric and adult formulations. Synergistic bronchodilatory and mucolytic actions.'], ['COVID-19 Adjunct','Adhatoda vasica extract with Tinospora cordifolia', 'Randomized Controlled Trial 2023 (PMID 38049897): significantly improved clinical markers, reduced symptom duration in mild COVID-19. Reduced inflammatory markers.'], ['Topical application','Leaf poultice or extract applied to skin', 'Wounds, ulcers, rheumatic joint pains — traditional topical anti-inflammatory.'], ] cw3 = [3.2*cm, 4.8*cm, usable_w-3.2*cm-4.8*cm] story.append(t3(clin3,cw3,bg=PURPLE)) story.append(P("CRITICAL MODERN RELEVANCE: Bromhexine and Ambroxol — two of the most prescribed mucolytic drugs worldwide — are direct synthetic derivatives of Vasicine from Adhatoda vasica. This represents one of the best examples of successful drug development from Ayurvedic plants.", NT)) story.append(Spacer(1,0.3*cm)) #══════════════════════════════════════════════ # PHYSIOLOGY #══════════════════════════════════════════════ story.append(HRFlowable(width="100%",thickness=2,color=colors.HexColor('#6a1b9a'),spaceAfter=6)) story.append(P("PHYSIOLOGY — MECHANISMS OF ACTION IN BODY SYSTEMS",H2)) story.append(P("A. Physiology of Wound Healing and Skin Repair — Relevant to Kumari",H3)) phys1 = [ P("<b>Normal Wound Healing — 4 Phases:</b>",ST), P("<b>Phase 1 — Haemostasis (Seconds to Hours):</b> Platelet activation and aggregation; coagulation cascade activated; fibrin clot formed; stops bleeding.", BL), P("<b>Phase 2 — Inflammatory Phase (Days 1 to 5):</b> Neutrophils and macrophages recruited by cytokines (Interleukin-1 (IL-1), Tumor Necrosis Factor-alpha (TNF-alpha)). Macrophages release growth factors: Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-beta), Epidermal Growth Factor (EGF). Debridement of wound.", BL), P("<b>Phase 3 — Proliferative Phase (Days 5 to 21):</b> Fibroblasts migrate into wound and produce Type I and III collagen. Angiogenesis (new blood vessel formation). Granulation tissue formation. Epithelialization — keratinocytes migrate and cover wound surface.", BL), P("<b>Phase 4 — Remodeling Phase (Weeks to Years):</b> Type III collagen replaced by Type I collagen (stronger). Wound contraction via myofibroblasts. Tensile strength progressively increases.", BL), Spacer(1,0.1*cm), P("<u>How Kumari Acts at Each Phase:</u>",ST), P("- Acemannan activates macrophages in Phase 2 — releases more growth factors — faster transition to proliferative phase.", BL), P("- Acemannan directly stimulates fibroblast proliferation in Phase 3 — more collagen synthesis — faster granulation tissue.", BL), P("- Bradykinase enzyme reduces bradykinin-mediated pain and erythema in inflammatory phase.", BL), P("- Vitamins A, C, E support antioxidant protection of healing tissue; Vitamin C essential for collagen cross-linking.", BL), P("- Moisturizing effect maintains wound hydration — faster epithelialization.", BL), P("- Net result: Meta-analysis 2024 confirms significantly shorter burn wound healing time and lower pain scores.", BL), ] story.append(box(phys1,bg=ORANGE,border=colors.HexColor('#e65100'))) story.append(Spacer(1,0.25*cm)) story.append(P("B. Physiology of Glucose Metabolism and Taste — Relevant to Meshashringi",H3)) phys2 = [ P("<b>Normal Glucose Absorption Pathway:</b>",ST), P("Dietary carbohydrates → hydrolysis by Salivary amylase → Pancreatic amylase → Maltase, Sucrase, Lactase (brush border enzymes on intestinal microvilli) → Monosaccharides (Glucose, Fructose, Galactose) → absorbed via SGLT-1 (Sodium-Glucose co-Transporter 1) at intestinal brush border → enters portal circulation → hepatic glucose metabolism — stored as Glycogen (via insulin-stimulated GLUT-2) or used for energy.", BL), Spacer(1,0.05*cm), P("<b>Normal Sweet Taste Perception:</b>",ST), P("Sweet tastants (sugars, artificial sweeteners) bind T1R2/T1R3 heterodimer receptor on taste bud cells — activates G-protein (Gustducin) → opens cation channels → depolarization → Nerve impulse → Sweet taste sensation in brain cortex.", BL), Spacer(1,0.1*cm), P("<u>How Meshashringi Disrupts These Pathways:</u>",ST), P("- INTESTINAL ABSORPTION: Gymnemic acids have similar molecular structure to glucose — occupy SGLT-1 glucose binding sites competitively — block glucose entry into intestinal cells — reduces postprandial blood glucose rise.", BL), P("- ALPHA-GLUCOSIDASE INHIBITION: Gymnemic acids inhibit intestinal brush border alpha-glucosidase enzyme — prevents starch and disaccharide breakdown — reduces substrate available for absorption (same mechanism as Acarbose drug).", BL), P("- TASTE RECEPTOR BLOCKADE: Gurmarin and Gymnemic acids occupy T1R2/T1R3 receptor — sweet tastants cannot bind — no G-protein activation — no sweet taste perception. Effect lasts 10 to 45 minutes. Reduces craving for sweets.", BL), P("- BETA-CELL REGENERATION: Gymnemic acids promote pancreatic beta cell proliferation and differentiation from ductal cells — increases functional beta cell mass — improves insulin reserve long-term.", BL), P("- INSULIN SECRETAGOGUE: Increases insulin secretion from beta cells — independent of glucose — lowers blood glucose.", BL), ] story.append(box(phys2,bg=TEAL,border=colors.HexColor('#006064'))) story.append(Spacer(1,0.25*cm)) story.append(P("C. Physiology of Respiratory System — Relevant to Vaasa",H3)) phys3 = [ P("<b>Normal Airway Physiology:</b>",ST), P("Airways lined with pseudostratified columnar ciliated epithelium with goblet cells. Goblet cells secrete mucus — traps inhaled particles. Cilia beat at 1000 beats per minute — move mucus toward trachea (Mucociliary clearance). Smooth muscle in bronchial wall regulated by: Sympathetic (beta-2 adrenergic stimulation → bronchodilation via cAMP) and Parasympathetic (muscarinic M3 stimulation → bronchoconstriction via cGMP).", BL), Spacer(1,0.05*cm), P("<b>Pathophysiology of Asthma and COPD (Chronic Obstructive Pulmonary Disease):</b>",ST), P("ASTHMA: Airway hyperresponsiveness + inflammation + reversible bronchospasm. Mast cell and Th2 lymphocyte activation — Immunoglobulin E (IgE)-mediated mast cell degranulation — release of Histamine, Leukotrienes (LTC4, LTD4), Prostaglandin D2 (PGD2) — bronchospasm + edema + mucus production. Eosinophil infiltration — airway remodeling.", BL), P("COPD: Irreversible airway obstruction. Neutrophilic inflammation — Interleukin-8 (IL-8) — protease-antiprotease imbalance — alveolar destruction (emphysema). Mucus hypersecretion (chronic bronchitis). Goblet cell hyperplasia.", BL), Spacer(1,0.1*cm), P("<u>How Vaasa Acts:</u>",ST), P("- VASICINE — PDE (Phosphodiesterase) inhibition — increases cAMP in bronchial smooth muscle — bronchodilation (similar mechanism to Theophylline). Direct beta-2 adrenergic-like effect also contributes.", BL), P("- VASICINE — stimulates mucosal secretory cells — increases mucus volume and reduces viscosity — easier expectoration. Stimulates type II pneumocyte surfactant production (like Ambroxol).", BL), P("- VASICINE / VASICINONE — inhibit COX and LOX — reduce Leukotrienes (LTC4, LTD4) — reduce allergic bronchoconstriction mediators in asthma.", BL), P("- BROMHEXINE (synthetic vasicine derivative) — reduces disulfide bonds in mucus glycoproteins — reduces mucus viscosity — easier clearance. Increases lysosomal enzyme activity in bronchial cells.", BL), P("- Net effect: Opens airways + reduces mucus plugging + reduces airway inflammation = three-pronged respiratory benefit.", BL), ] story.append(box(phys3,bg=PURPLE,border=colors.HexColor('#4a148c'))) story.append(Spacer(1,0.3*cm)) #══════════════════════════════════════════════ # PATHOLOGY #══════════════════════════════════════════════ story.append(HRFlowable(width="100%",thickness=2,color=colors.HexColor('#b71c1c'),spaceAfter=6)) story.append(P("PATHOLOGY — DISEASE STATES AND DRUG ROLES",H2)) story.append(P("A. Pathological Conditions Addressed by Kumari",H3)) path1 = [ ['Disease or Condition','Pathological Mechanism','Role of Kumari'], ['Burn Wounds (1st and 2nd degree)', 'Thermal injury destroys epidermis and dermis. Inflammatory cascade: histamine, bradykinin, prostaglandins — pain, edema. Risk of secondary infection. Impaired epithelialization.', 'Acemannan accelerates fibroblast proliferation and epithelialization. Bradykinase reduces pain and inflammation. Antibacterial activity reduces infection risk. Meta-analysis 2024 (PMID 38605441) confirms significant benefit.'], ['Diabetic Foot Ulcer', 'Peripheral neuropathy (loss of protective sensation) + peripheral vascular disease (impaired blood supply) + hyperglycemia (impairs neutrophil function, collagen synthesis, growth factor signaling) = chronic non-healing ulcer.', 'Aloe vera gel improves local blood flow, reduces infection, stimulates collagen synthesis, provides antioxidant protection. Randomized Controlled Trial 2024 (PMID 37670716) confirms healing benefit.'], ['Constipation', 'Reduced intestinal motility, hard stools, impaired defecation. Causes: low fiber, dehydration, hypothyroidism, opiate use, pelvic floor dysfunction.', 'Anthraquinone glycosides (Aloin/Barbaloin) stimulate large intestinal peristalsis — increase colonic secretions — soft stools — relief. Dose-dependent: low dose tonic, high dose cathartic.'], ['Peptic Ulcer Disease', 'Imbalance between aggressive factors (Hydrochloric acid, Pepsin, Helicobacter pylori, NSAIDs) and defensive factors (mucus, bicarbonate, prostaglandin E2). Mucosal erosion, ulcer formation.', 'Aloe vera gel inhibits excess HCl secretion. Promotes gastric mucosal healing. Acemannan anti-inflammatory action. Reduces H. pylori colonization (antibacterial activity).'], ['Psoriasis', 'Th17 and Th1 mediated autoimmune skin disorder. Keratinocyte hyperproliferation. Epidermal thickening, scaling plaques. Inflammatory infiltrate (neutrophils, Th17 cells) in dermis.', 'Double-blind Randomized Controlled Trial: Aloe vera 0.5% cream vs placebo — significant reduction in psoriasis plaques. Anti-inflammatory (reduces IL-17, IL-23), antiproliferative effect on keratinocytes.'], ['Metabolic Syndrome / Hyperlipidemia', 'Visceral obesity, dyslipidemia (raised LDL and triglycerides, low HDL), insulin resistance, hypertension. Increased cardiovascular risk.', 'Reduces total cholesterol, LDL, triglycerides. Raises HDL. Clinical study of 5000 cardiac patients: reduced anginal attacks, allowed drug tapering. Lowers fasting blood glucose.'], ] cw_p = [3.4*cm, 4.8*cm, usable_w-3.4*cm-4.8*cm] story.append(t3(path1,cw_p,bg=ORANGE)) story.append(Spacer(1,0.25*cm)) story.append(P("B. Pathological Conditions Addressed by Meshashringi",H3)) path2 = [ ['Disease or Condition','Pathological Mechanism','Role of Meshashringi'], ['Prediabetes (Impaired Glucose Tolerance)', 'Borderline hyperglycemia: fasting glucose 100 to 125 mg/dL or 2-hour glucose 140 to 199 mg/dL. Beta-cell compensation failing. High risk of progression to Type 2 Diabetes Mellitus.', 'Gymnemic acids: reduce intestinal glucose absorption, stimulate beta-cell regeneration, improve insulin sensitivity. Randomized Controlled Trial 2021 (PMID 32460589): significantly improved insulin secretion and sensitivity in impaired glucose tolerance patients.'], ['Type 2 Diabetes Mellitus', 'Insulin resistance (peripheral tissues) + progressive beta-cell failure. Hyperglycemia causes glycosylation of proteins (HbA1c increases), oxidative stress, microvascular disease (nephropathy, retinopathy, neuropathy), macrovascular disease (coronary artery disease, stroke).', 'Multiple mechanisms: alpha-glucosidase inhibition, SGLT-1 blockade, beta-cell regeneration, insulin secretion stimulation. Meta-analysis 2021 (PMID 34467577): significant reduction in HbA1c and fasting blood glucose. Can be used alongside conventional antidiabetic drugs.'], ['Obesity and Food Addiction (Sweet Craving)', 'Hypothalamic reward circuits driven by dopamine and endocannabinoid signaling respond to sweetness. Highly palatable sweet foods trigger overconsumption. Leptin resistance in obesity perpetuates hunger. Excess caloric intake from sweets.', 'Gymnemic acids and Gurmarin block T1R2/T1R3 sweet taste receptors — sweetness imperceptible — reduces hedonic eating of sweet foods. Randomized Controlled Trial 2025 (PMID 40944109): reduces motivation to eat sweet foods. Randomized Controlled Trial 2022 (PMID 36558446): 14-day use significantly reduces sugar cravings.'], ['Dyslipidemia', 'Elevated LDL, VLDL, triglycerides; low HDL. Consequence of insulin resistance and metabolic syndrome. Risk factor for atherosclerosis, coronary artery disease.', 'Gymnemic acids inhibit intestinal lipid absorption and enhance hepatic lipid metabolism. Reduces total cholesterol, LDL, VLDL, triglycerides. Raises HDL. Complementary to statin therapy.'], ] story.append(t3(path2,cw_p,bg=TEAL)) story.append(Spacer(1,0.25*cm)) story.append(P("C. Pathological Conditions Addressed by Vaasa",H3)) path3 = [ ['Disease or Condition','Pathological Mechanism','Role of Vaasa'], ['Bronchial Asthma', 'IgE-mediated Th2 response → mast cell degranulation → release of Histamine, Leukotrienes (LTC4, LTD4), Prostaglandin D2 → acute bronchospasm (early phase) + eosinophil recruitment → airway remodeling (late phase). Excessive mucus production with high viscosity — mucus plugging.', 'Vasicine: bronchodilation via cAMP increase (PDE inhibition). Reduces Leukotriene production (LOX inhibition). Reduces mucus viscosity (expectorant). Triple action: bronchodilation + anti-inflammation + mucolytic.'], ['Chronic Obstructive Pulmonary Disease (COPD)', 'Chronic irreversible airway obstruction. Emphysema: alveolar wall destruction by neutrophil elastase (protease-antiprotease imbalance). Chronic Bronchitis: mucus hypersecretion, goblet cell hyperplasia. Forced Expiratory Volume in 1 second (FEV1) progressively declines.', 'Vasicine/Bromhexine: mucolytic — reduces viscid mucus hypersecretion. Vasicine: bronchodilatory — reduces airway resistance. Anti-inflammatory — reduces neutrophilic airway inflammation. Adjuvant role improving quality of life and reducing exacerbations.'], ['Pulmonary Tuberculosis', 'Mycobacterium tuberculosis infects alveolar macrophages — evades phagolysosomal killing — caseous necrotic granuloma formation — cavity formation in lung. AFB (Acid-Fast Bacillus) positive sputum.', 'Vasicine inhibits Mycobacterium tuberculosis growth. Traditional adjunct alongside anti-tuberculosis therapy. Reduces excessive mucus in cavitary tuberculosis. Haemostatic (tannins) — reduces haemoptysis.'], ['COVID-19 Respiratory Infection', 'SARS-CoV-2 virus enters via ACE2 receptor on type II pneumocytes. Cytokine storm: massive IL-6, TNF-alpha, IL-1beta elevation. Viral pneumonitis, Acute Respiratory Distress Syndrome (ARDS), mucus production.', 'Randomized Controlled Trial 2023 (PMID 38049897): Adhatoda vasica + Tinospora cordifolia significantly improved clinical and molecular markers, reduced symptom duration in mild COVID-19 patients. Anti-inflammatory, expectorant, antiviral combination effect.'], ['Post-Partum Haemorrhage (Traditional Use)', 'Uterine atony (failure of uterus to contract after delivery) — excessive blood loss from placental site. Life-threatening obstetric emergency.', 'Vasicine causes uterine smooth muscle contraction — oxytocic effect. Traditional use to stimulate uterine contractions. NOTE: Strictly contraindicated during pregnancy due to abortifacient risk.'], ] story.append(t3(path3,cw_p,bg=PURPLE)) story.append(Spacer(1,0.25*cm)) #── ADULTERANT QUICK REF ── story.append(HRFlowable(width="100%",thickness=1.5,color=colors.HexColor('#37474f'),spaceAfter=5)) story.append(P("ADULTERANT AND VARIETY IDENTIFICATION — QUICK REFERENCE",H3)) adult = [ ['Drug','Genuine Identification Features','Adulterants or Varieties','Detection Method'], ['Kumari\n(Aloe vera)','Dark brown to black solid mass; brittle fracture; disagreeable nauseating odour; bitter taste', '1. Black catechu (Katha)\n2. Dust or sand\nVARIETIES: Curacao (yellowish), Cape (greenish), Socotrine (dark brown glossy), Zingiber (light blue)', 'Test for anthraquinones (Borntraeger reaction — pink/red with ammonia). Check colour, odour (no nauseating smell in adulterants). Sand/dust detected by ash value. Varieties distinguished by colour.'], ['Meshashringi\n(Gymnema sylvestre)','Simple opposite pubescent leaves; ovate/elliptic; 3-6 cm leaf blade; reticulate venation; bitter taste that blocks sweetness temporarily', 'Gymnema montanum (similar morphology). Check venation and pubescence pattern.', 'DEFINITIVE TEST: Chew leaf — if sweetness of sugar is blocked for 10 to 45 minutes = genuine Meshashringi. Microscopy: unicellular curved trichomes, anomocytic stomata.'], ['Vaasa\n(Adhatoda vasica)','Lanceolate leaf 12-20 cm; glabrous upper surface; brittle fracture; characteristic odour; bitter taste', '1. Twigs and inflorescence (spikes) admixed\n2. Adhatoda beddomi (substitute)', 'Check leaf shape: must be lanceolate with pointed apex. Upper surface must be smooth (glabrous). A. beddomi: smaller leaves, different venation pattern. Microscopy: anisocytic stomata, calcium oxalate crystals.'], ] cw_a = [3*cm, 4*cm, 3.8*cm, usable_w-3*cm-4*cm-3.8*cm] story.append(t3(adult,cw_a,bg=GREY)) story.append(Spacer(1,0.2*cm)) #── SUMMARY TABLE ── story.append(HRFlowable(width="100%",thickness=2,color=colors.HexColor('#1a237e'),spaceAfter=5)) story.append(P("COMPARATIVE SUMMARY — QUICK REVISION TABLE",H3)) summary = [ ['Parameter','Kumari (Aloe vera)','Meshashringi (Gymnema sylvestre)','Vaasa (Adhatoda vasica)'], ['Botanical Family','Liliaceae (modern: Asphodelaceae)','Asclepiadaceae (modern: Apocynaceae)','Acanthaceae'], ['Part Used','Leaf juice (inspissated latex)','Dried leaf','Leaves and terminal leafy branches'], ['Primary Action','Wound healing, laxative, anti-inflammatory','Antidiabetic, sweet taste blocker, anti-obesity','Bronchodilator, mucolytic, expectorant'], ['Key Active Constituent','Aloin (anthraquinone), Acemannan (polysaccharide)','Gymnemic acids (triterpenoid saponins), Gurmarin (polypeptide)','Vasicine (quinazoline alkaloid)'], ['Taste','Bitter','Bitter (blocks sweet taste)','Bitter'], ['Odour','Disagreeable, nauseating','Unpleasant','Characteristic (distinct)'], ['Fracture','Brittle (dried juice mass)','Not specified','Brittle (dried leaves)'], ['Modern Drug Derived','No direct synthetic derivative; Acemannan used in wound care products','No direct derivative; functional food use','Bromhexine HCl and Ambroxol — globally used mucolytics'], ['Top Modern Evidence','Meta-analysis 2024 burns\n(PMID 38605441)','Meta-analysis 2021 diabetes\n(PMID 34467577)','RCT 2023 COVID-19\n(PMID 38049897)'], ['Contraindications','Pregnancy (stimulant laxative), IBD, hemorrhoids for oral latex form','Monitor in Type 1 Diabetes (hypoglycemia risk)','PREGNANCY (abortifacient), active bleeding'], ['Key Adulterant','Black catechu, dust, sand','Gymnema montanum','Twigs, inflorescence; Adhatoda beddomi'], ] cw_s = [4.0*cm, (usable_w-4.0*cm)/3, (usable_w-4.0*cm)/3, (usable_w-4.0*cm)/3] story.append(t3(summary,cw_s,bg=BLUE)) story.append(Spacer(1,0.2*cm)) #── FULL FORMS GLOSSARY ── story.append(P("Full Forms Reference: ACE2 = Angiotensin-Converting Enzyme 2 | ALP = Alkaline Phosphatase | ALT = Alanine Transaminase | ARDS = Acute Respiratory Distress Syndrome | AST = Aspartate Transaminase | BMD = Bone Mineral Density | cAMP = cyclic Adenosine Monophosphate | COX = Cyclooxygenase | COPD = Chronic Obstructive Pulmonary Disease | DPP-4 = Dipeptidyl Peptidase-4 | EGF = Epidermal Growth Factor | FEV1 = Forced Expiratory Volume in 1 second | HbA1c = Glycated Hemoglobin A1c | HDL = High-Density Lipoprotein | IgE = Immunoglobulin E | IL = Interleukin | LDL = Low-Density Lipoprotein | LOX = Lipoxygenase | LTB4 = Leukotriene B4 | LTC4 = Leukotriene C4 | LTD4 = Leukotriene D4 | NF-kB = Nuclear Factor kappa Beta | NK = Natural Killer cell | NSAID = Non-Steroidal Anti-inflammatory Drug | PDE = Phosphodiesterase | PDGF = Platelet-Derived Growth Factor | PGE2 = Prostaglandin E2 | PMID = PubMed Identifier | RCT = Randomized Controlled Trial | ROS = Reactive Oxygen Species | SGLT-1 = Sodium-Glucose co-Transporter 1 | SOD = Superoxide Dismutase | TGF-beta = Transforming Growth Factor-beta | TNF-alpha = Tumor Necrosis Factor-alpha | VLDL = Very Low-Density Lipoprotein",SM)) story.append(Spacer(1,0.15*cm)) story.append(P("References: PMID 38605441 (Aloe vera burns meta-analysis 2024) | PMID 36264753 (Aloe vera burns 2022) | PMID 37670716 (Aloe vera diabetic foot ulcer RCT 2024) | PMID 38229162 (Aloe vera pressure ulcer RCT 2024) | PMID 34467577 (Gymnema sylvestre diabetes meta-analysis 2021) | PMID 32460589 (Gymnema sylvestre impaired glucose tolerance RCT 2021) | PMID 36558446 (Gymnema sugar cravings RCT 2022) | PMID 40944109 (Gymnema sweet food motivation RCT 2025) | PMID 38049897 (Adhatoda vasica COVID-19 RCT 2023) | Frontiers Nutrition 2025 (Aloe vera phytochemistry review) | MDPI IJMS 2025 (Gymnema as multi-target antidiabetic) | Andrews Diseases of the Skin E-Book",SM)) doc = SimpleDocTemplate(OUTPUT, pagesize=A4, rightMargin=1.8*cm, leftMargin=1.8*cm, topMargin=2*cm, bottomMargin=2*cm, title="Kumari Meshashringi Vaasa Pharmacognosy Notes", author="DG-7 Study Notes") doc.build(story) print("SUCCESS:", OUTPUT) PYEOF